{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/om400633z.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": "error", "content": "<p>The\nmonosubstituted ferrocenyl-amide phosphine ligands PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc and (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCOFc and the disubstituted ferrocenyl-amide\ndiphosphine (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCO)<sub>2</sub>Fc have been synthesized and used to prepare the gold chloride\nderivatives [AuCl\u00ad(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc)],\n[Au<sub>2</sub>Cl<sub>2</sub>{(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCOFc}], and [Au<sub>2</sub>Cl<sub>2</sub>{(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCO)<sub>2</sub>Fc}] or the silver\nspecies [Ag\u00ad(OTf)\u00ad(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc)<sub>2</sub>] and [Ag\u00ad(OTf)\u00ad(PPh<sub>3</sub>)\u00ad(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc)]. In the gold complexes the chloro ligands\ncan be easily substituted by several biologically relevant thiolates\nsuch as 2-mercaptonicotinic acid, 2-thiocytosine, 2-thiouracil, 2-mercaptopurine,\nand 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-<sc>d</sc>-glucopyranosato,\naffording the gold phosphine thiolate derivatives. In addition, the\ngold phosphine thiolates of the closely related 1,1\u2032-bis\u00ad(diphenylphosphine)\u00adferrocene\nligand have been prepared in order to compare their biological activities.\nThe antiproliferative activity of these compounds has been tested\nby the MTT viability assay in two murine cell lines, NIH-3T3 (mouse\nembryonic fibroblasts) and PC-12 (pheochromocytoma of the rat adrenal\nmedulla), and two human cell lines, A-549 (adenocarcinomic human alveolar\nbasal epithelial cells) and Hep-G2 (hepatocellular carcinoma). The\namide-phosphine ligands are not active, whereas the chloro-gold derivatives\nhave good antiproliferative activity in the murine cell lines and very\nlow activity in the human cell lines. The silver complexes are less\nactive than the gold derivatives. The gold thiolate complexes have\nmoderate to very good cytotoxic activity for all of the ligands, showing\nexcellent IC<sub>50</sub> values for the thiolate complexes of the\namide-phosphines PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc\nand (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N)<sub>2</sub>COFc\nand dppf.</p>", "clean_text": "The monosubstituted ferrocenyl-amide phosphine ligands PPh2CH2CH2NHCOFc and (PPh2CH2CH2)2NCOFc and the disubstituted ferrocenyl-amide diphosphine (PPh2CH2CH2NHCO)2Fc have been synthesized and used to prepare the gold chloride derivatives [AuCl(PPh2CH2CH2NHCOFc)], [Au2Cl2{(PPh2CH2CH2)2NCOFc}], and [Au2Cl2{(PPh2CH2CH2NHCO)2Fc}] or the silver species [Ag(OTf)(PPh2CH2CH2NHCOFc)2] and [Ag(OTf)(PPh3)(PPh2CH2CH2NHCOFc)]. In the gold complexes the chloro ligands can be easily substituted by several biologically relevant thiolates such as 2-mercaptonicotinic acid, 2-thiocytosine, 2-thiouracil, 2-mercaptopurine, and 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-d-glucopyranosato, affording the gold phosphine thiolate derivatives. In addition, the gold phosphine thiolates of the closely related 1,1'-bis(diphenylphosphine)ferrocene ligand have been prepared in order to compare their biological activities. The antiproliferative activity of these compounds has been tested by the MTT viability assay in two murine cell lines, NIH-3T3 (mouse embryonic fibroblasts) and PC-12 (pheochromocytoma of the rat adrenal medulla), and two human cell lines, A-549 (adenocarcinomic human alveolar basal epithelial cells) and Hep-G2 (hepatocellular carcinoma). The amide-phosphine ligands are not active, whereas the chloro-gold derivatives have good antiproliferative activity in the murine cell lines and very low activity in the human cell lines. The silver complexes are less active than the gold derivatives. The gold thiolate complexes have moderate to very good cytotoxic activity for all of the ligands, showing excellent IC50 values for the thiolate complexes of the amide-phosphines PPh2CH2CH2NHCOFc and (PPh2CH2CH2N)2COFc and dppf.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>The antitumoral properties of metallic\ncomplexes started with the great success of cisplatin and the second-\nor third-generation drugs carboplatin, paraplatin, and oxaliplatin,\nwhich open a new field for exploring the biological applications of\nmetal-based drugs. Although platinum drugs\nare largely used in cancer treatment, their toxicity and the development\nof platinum drug resistance in cell lines has led to a greater research\nin other metallic complexes, as for example ruthenium, for which two\ncomplexes have been successfully entered into clinical trials. Gold complexes, which are largely known as good\nantiarthritic drugs, have attracted much attention because of their\nstrong antiproliferative activity, together with other biological\nproperties found for these complexes such as antimicrobial activity,\nanti-VIH, antimalaria, etc. Several gold\ncompounds, including gold\u00ad(I) and gold\u00ad(III) derivatives, have shown promising cytotoxic activity,\nin some cases overcoming cisplatin resistance to specific cancer cells,\nand in addition they have shown a mechanism of action clearly different\nfrom that of platinum drugs. Several targets have been identified\nfor gold complexes, the inhibition of thioredoxine reductase being\nthe most important to date.\n</p>", "clean_text": "Introduction\n\nThe antitumoral properties of metallic complexes started with the great success of cisplatin and the second- or third-generation drugs carboplatin, paraplatin, and oxaliplatin, which open a new field for exploring the biological applications of metal-based drugs. Although platinum drugs are largely used in cancer treatment, their toxicity and the development of platinum drug resistance in cell lines has led to a greater research in other metallic complexes, as for example ruthenium, for which two complexes have been successfully entered into clinical trials. Gold complexes, which are largely known as good antiarthritic drugs, have attracted much attention because of their strong antiproliferative activity, together with other biological properties found for these complexes such as antimicrobial activity, anti-VIH, antimalaria, etc. Several gold compounds, including gold(I) and gold(III) derivatives, have shown promising cytotoxic activity, in some cases overcoming cisplatin resistance to specific cancer cells, and in addition they have shown a mechanism of action clearly different from that of platinum drugs. Several targets have been identified for gold complexes, the inhibition of thioredoxine reductase being the most important to date. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<p>Organometallic\ncomplexes have also been proven to be excellent candidates as antitumoral\nagents; among them ferrocene and its derivatives have aroused great\ninterest because of their potential biological applications. Ferrocene itself and its derivatives have been\nused as cytotoxic and antianemic agents within the area of medicinal\napplications. The ferrocenyl group has\nbeen incorporated into the structure of a number of biologically active\nmolecules such as antibiotic, anticancer, and malaria drugs, resulting in an increase of the activity. Thus, the ferrocene moiety\nhas proved to be a successful addition to penicillin and cephalosporine,\nenhancing their antibacterial activity, to tamoxifen, increasing its\nantitumor properties, or to known malaria therapeutics, increasing\ntheir efficacy toward chloroquine-resistant strains of the parasite.\nFurthermore, the antiproliferative activity of compounds based on\npolyphenols is dramatically activated by the introduction of the ferrocene\ngroup.\n</p>", "clean_text": "Organometallic complexes have also been proven to be excellent candidates as antitumoral agents; among them ferrocene and its derivatives have aroused great interest because of their potential biological applications. Ferrocene itself and its derivatives have been used as cytotoxic and antianemic agents within the area of medicinal applications. The ferrocenyl group has been incorporated into the structure of a number of biologically active molecules such as antibiotic, anticancer, and malaria drugs, resulting in an increase of the activity. Thus, the ferrocene moiety has proved to be a successful addition to penicillin and cephalosporine, enhancing their antibacterial activity, to tamoxifen, increasing its antitumor properties, or to known malaria therapeutics, increasing their efficacy toward chloroquine-resistant strains of the parasite. Furthermore, the antiproliferative activity of compounds based on polyphenols is dramatically activated by the introduction of the ferrocene group. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>We have previously reported\non the synthesis of some ferrocene conjugates with amino acid esters,\nthe formation of the corresponding gold complexes, and the evaluation\nof their antiproliferative activity. The\ncomplexes showed moderate to significant cytotoxic activity, and a\nsynergic effect between ferrocene and gold was observed. As the structure\u2013activity\nrelationship in gold complexes shows that the gold atom exerts the\ncytotoxic activity, that a phosphine ligand enhanced their activity,\nand that other auxiliary ligands are important in taking the gold\ncenter to its biological target, we believe that a combination between\na phosphine ligand with ferrocene moieties and relevant biological\nthiolates would be a good combination for gold-based drugs. Therefore,\nhere we report on the synthesis of ferrocenyl amide-phosphine ligands,\nwhich could also be important because of their ability to form hydrogen\nbonds, their coordination to the gold chloride fragment, and further\nsubstitution for several thiolate ligands. An evaluation of their\nantiproliferative activity has been carried out in two murine and\ntwo human cell lines.</p>", "clean_text": "We have previously reported on the synthesis of some ferrocene conjugates with amino acid esters, the formation of the corresponding gold complexes, and the evaluation of their antiproliferative activity. The complexes showed moderate to significant cytotoxic activity, and a synergic effect between ferrocene and gold was observed. As the structure-activity relationship in gold complexes shows that the gold atom exerts the cytotoxic activity, that a phosphine ligand enhanced their activity, and that other auxiliary ligands are important in taking the gold center to its biological target, we believe that a combination between a phosphine ligand with ferrocene moieties and relevant biological thiolates would be a good combination for gold-based drugs. Therefore, here we report on the synthesis of ferrocenyl amide-phosphine ligands, which could also be important because of their ability to form hydrogen bonds, their coordination to the gold chloride fragment, and further substitution for several thiolate ligands. An evaluation of their antiproliferative activity has been carried out in two murine and two human cell lines.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<title>Results and Discussion</title><title>Synthesis and Structural\nCharacterization</title><p>As phosphine ligands are important in gold\ncomplexes in improving the cytotoxic activity of the complex, probably\nbecause they allow the gold compound to better cross the plasma membrane,\nwe have prepared several ferrocenyl-amide phosphines in order to form\nthe gold complexes and test their antiproliferative activity. Monosubstituted\nspecies such as PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc\nand (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCOFc\nand the disubstituted derivative (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCO)<sub>2</sub>Fc have been chosen as suitable ferrocenyl\namide-phosphine ligands, and also in order to compare their activity\nwith that of other ferrocenyl phosphines, we have added 1,1\u2032-bis\u00ad(diphenylphosphino)\u00adferrocene\nas a comparison (Chart ).</p>", "clean_text": "Results and Discussion\n\nSynthesis and Structural Characterization\n\nAs phosphine ligands are important in gold complexes in improving the cytotoxic activity of the complex, probably because they allow the gold compound to better cross the plasma membrane, we have prepared several ferrocenyl-amide phosphines in order to form the gold complexes and test their antiproliferative activity. Monosubstituted species such as PPh2CH2CH2NHCOFc and (PPh2CH2CH2)2NCOFc and the disubstituted derivative (PPh2CH2CH2NHCO)2Fc have been chosen as suitable ferrocenyl amide-phosphine ligands, and also in order to compare their activity with that of other ferrocenyl phosphines, we have added 1,1'-bis(diphenylphosphino)ferrocene as a comparison (Chart ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "figure", "classification": null, "content": "<fig fig-type=\"chart\" id=\"cht1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Ferrocene-Based Phosphines\nUsed</title>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0002.tif\"></graphic>\n</fig>", "clean_text": " 1  Ferrocene-Based Phosphines Used   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 7, "type": "text", "classification": "error", "content": "<p>The monosubstituted ferrocenyl-amide\nphosphines have been obtained by reaction of (chlorocarbonyl)\u00adferrocene\nwith NH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>PPh<sub>2</sub> or\nNH\u00ad(CH<sub>2</sub>CH<sub>2</sub>PPh<sub>2</sub>)<sub>2</sub> to give\nligand <bold>L1</bold> or <bold>L2</bold>, respectively (Scheme ). We have previously synthesized the disubstituted\nligand <bold>L3</bold> by a similar procedure, starting from 1,1\u2032-dichlorocarbonylferrocene. In both cases\nthe <sup>1</sup>H NMR spectra for <bold>L1</bold> and <bold>L2</bold> show a singlet for the protons of the unsubstituted cyclopentadienyl\nligand, two multiplets for the \u03b1 and \u03b2 protons of the\nsubstituted cyclopentadienyl units, and two multiplets for the methylene\nprotons. The <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR spectra gives only\none resonance at \u221220.9 for <bold>L1</bold>, where only one\nphosphorus atom is present, and two resonances at \u221220.1 and\n\u221221.5 ppm for <bold>L2</bold>, which indicates that both phosphorus\natoms are inequivalent because of the conformational rigidity imposed\non the molecule by the CpCO unit. The IR spectra show absorptions\narising for the amide groups at 1539 (N\u2013C\ue5fbO), 1601 (C\ue5fbO),\nand 3420 (NH) cm<sup>\u20131</sup> for <bold>L1</bold> and 1574\n(N\u2013C\ue5fbO) and 1598 (C\ue5fbO) cm<sup>\u20131</sup> for <bold>L2</bold>. In the mass spectra molecular peaks at <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 442 (100%) and 654 (50%) are observed.</p>", "clean_text": "The monosubstituted ferrocenyl-amide phosphines have been obtained by reaction of (chlorocarbonyl)ferrocene with NH2CH2CH2PPh2 or NH(CH2CH2PPh2)2 to give ligand L1 or L2, respectively (Scheme ). We have previously synthesized the disubstituted ligand L3 by a similar procedure, starting from 1,1'-dichlorocarbonylferrocene. In both cases the 1H NMR spectra for L1 and L2 show a singlet for the protons of the unsubstituted cyclopentadienyl ligand, two multiplets for the \u03b1 and \u03b2 protons of the substituted cyclopentadienyl units, and two multiplets for the methylene protons. The 31P{1H} NMR spectra gives only one resonance at -20.9 for L1, where only one phosphorus atom is present, and two resonances at -20.1 and -21.5 ppm for L2, which indicates that both phosphorus atoms are inequivalent because of the conformational rigidity imposed on the molecule by the CpCO unit. The IR spectra show absorptions arising for the amide groups at 1539 (N-C\ue5fbO), 1601 (C\ue5fbO), and 3420 (NH) cm-1 for L1 and 1574 (N-C\ue5fbO) and 1598 (C\ue5fbO) cm-1 for L2. In the mass spectra molecular peaks at m/z 442 (100%) and 654 (50%) are observed.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 8, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Synthesis of the Ferrocenyl Amide-Phosphine Ligands<xref rid=\"sch1-fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0008.tif\"></graphic>\n<p>\n<fn id=\"sch1-fn1\">\n<label>a</label>\n<p>Legend: (i) NH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>PPh<sub>2</sub>, (ii) NH\u00ad(CH<sub>2</sub>CH<sub>2</sub>PPh<sub>2</sub>)<sub>2</sub>.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 1  Synthesis of the Ferrocenyl Amide-Phosphine Ligands      a Legend: (i) NH2CH2CH2PPh2, (ii) NH(CH2CH2PPh2)2.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 9, "type": "text", "classification": ["else"], "content": "<p>\n<fn id=\"sch1-fn1\">\n<label>a</label>\n<p>Legend: (i) NH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>PPh<sub>2</sub>, (ii) NH\u00ad(CH<sub>2</sub>CH<sub>2</sub>PPh<sub>2</sub>)<sub>2</sub>.</p>\n</fn>\n</p><p>The reactions of <bold>L1</bold> with gold\u00ad(I)\nand silver\u00ad(I) complexes such as [AuCl\u00ad(tht)], Ag\u00ad(OTf), and [Ag\u00ad(OTf)\u00ad(PPh<sub>3</sub>)] afford the linear gold\u00ad(I) species [AuCl\u00ad(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc)] (<bold>1</bold>) and the three-coordinated\nsilver\u00ad(I) complexes [Ag\u00ad(OTf)\u00ad(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc)<sub>2</sub>] (<bold>2</bold>) and [Ag\u00ad(OTf)\u00ad(PPh<sub>3</sub>)\u00ad(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc)] (<bold>3</bold>), shown in Scheme .</p>", "clean_text": "  a Legend: (i) NH2CH2CH2PPh2, (ii) NH(CH2CH2PPh2)2.  \n\nThe reactions of L1 with gold(I) and silver(I) complexes such as [AuCl(tht)], Ag(OTf), and [Ag(OTf)(PPh3)] afford the linear gold(I) species [AuCl(PPh2CH2CH2NHCOFc)] (1) and the three-coordinated silver(I) complexes [Ag(OTf)(PPh2CH2CH2NHCOFc)2] (2) and [Ag(OTf)(PPh3)(PPh2CH2CH2NHCOFc)] (3), shown in Scheme .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 10, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Synthesis of Metal\nComplexes with the Ligand PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc<xref rid=\"sch2-fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0009.tif\"></graphic>\n<p>\n<fn id=\"sch2-fn1\">\n<label>a</label>\n<p>Legend: (i) [AuCl\u00ad(tht)]; (ii) <sup>1</sup>/<sub>2</sub> Ag\u00ad(OTf); (iii) [Ag\u00ad(OTf)\u00ad(PPh<sub>3</sub>)].</p>\n</fn>\n</p>\n</fig>", "clean_text": " 2  Synthesis of Metal Complexes with the Ligand PPh2CH2CH2NHCOFc      a Legend: (i) [AuCl(tht)]; (ii) 1/2 Ag(OTf); (iii) [Ag(OTf)(PPh3)].   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 11, "type": "text", "classification": "error", "content": "<p>\n<fn id=\"sch2-fn1\">\n<label>a</label>\n<p>Legend: (i) [AuCl\u00ad(tht)]; (ii) <sup>1</sup>/<sub>2</sub> Ag\u00ad(OTf); (iii) [Ag\u00ad(OTf)\u00ad(PPh<sub>3</sub>)].</p>\n</fn>\n</p><p>Complexes <bold>1</bold>\u2013<bold>3</bold> have been characterized by means of <sup>1</sup>H, <sup>31</sup>P\u00ad{<sup>1</sup>H}, and <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR spectroscopy.\nThe <sup>1</sup>H NMR spectra for all of the complexes show mainly\nthe resonances arising from the ferrocene amide-phosphine ligand displaced\nafter the coordination of the gold and silver centers, together with\nthe resonances for the phenylic protons. The <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR spectra are indicative of coordination of the metal. A low-field\ndisplacement is observed at 24.3 ppm in the case of gold and in the\nrange 2\u201312 ppm for the silver complexes. In the <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR spectrum of complex <bold>2</bold> a broad signal\nappears at room temperature that splits into two doublets at \u221260\n\u00b0C, because of the coupling of the phosphorus atoms with the\ntwo different silver nuclei, <sup>107</sup>Ag and <sup>109</sup>Ag.\nFor the spectrum of complex <bold>3</bold> also a broad signal appears;\nat low temperature (\u221260 \u00b0C) the spectrum is complex because\nusually these P\u2013Ag\u2013P\u2032 systems should appear as\nan AB system, which are further coupled to both silver nuclei; this\nmeans that each of the four resonances in the AB spectrum splits into\ntwo doublets. However, an equilibrium with the homoleptic species\n[Ag\u00ad(OTf)\u00ad(PPh<sub>3</sub>)<sub>2</sub>] and [Ag\u00ad(OTf)\u00ad(L1)<sub>2</sub>] (<bold>2</bold>) is observed, and it is possible to see the resonances\narising for all of the compounds.</p>", "clean_text": "  a Legend: (i) [AuCl(tht)]; (ii) 1/2 Ag(OTf); (iii) [Ag(OTf)(PPh3)].  \n\nComplexes 1-3 have been characterized by means of 1H, 31P{1H}, and 13C{1H} NMR spectroscopy. The 1H NMR spectra for all of the complexes show mainly the resonances arising from the ferrocene amide-phosphine ligand displaced after the coordination of the gold and silver centers, together with the resonances for the phenylic protons. The 31P{1H} NMR spectra are indicative of coordination of the metal. A low-field displacement is observed at 24.3 ppm in the case of gold and in the range 2-12 ppm for the silver complexes. In the 31P{1H} NMR spectrum of complex 2 a broad signal appears at room temperature that splits into two doublets at -60 \u00b0C, because of the coupling of the phosphorus atoms with the two different silver nuclei, 107Ag and 109Ag. For the spectrum of complex 3 also a broad signal appears; at low temperature (-60 \u00b0C) the spectrum is complex because usually these P-Ag-P' systems should appear as an AB system, which are further coupled to both silver nuclei; this means that each of the four resonances in the AB spectrum splits into two doublets. However, an equilibrium with the homoleptic species [Ag(OTf)(PPh3)2] and [Ag(OTf)(L1)2] (2) is observed, and it is possible to see the resonances arising for all of the compounds.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 12, "type": "text", "classification": ["else"], "content": "<p>For all compounds <bold>1</bold>\u2013<bold>3</bold> the mass spectrum shows the molecular ion,\nwhile the base peaks correspond to the fragments [M \u2013 Cl]<sup>+</sup> (<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 638), [M \u2013\nOTf]<sup>+</sup> (<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 840) and [M\n\u2013 PPh<sub>3</sub>]<sup>+</sup> (<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 548) for <bold>1</bold>\u2013<bold>3</bold>, respectively.</p>", "clean_text": "For all compounds 1-3 the mass spectrum shows the molecular ion, while the base peaks correspond to the fragments [M - Cl]+ (m/z 638), [M - OTf]+ (m/z 840) and [M - PPh3]+ (m/z 548) for 1-3, respectively.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 13, "type": "text", "classification": ["else"], "content": "<p>Substitution reactions have been carried out with complex <bold>1</bold>, and therefore, treatment with thiols such as 2-mercaptonicotic\nacid, 2-thiocytosine, 2-thiouracil, and 6-mercaptopurine in the presence\nof K<sub>2</sub>CO<sub>3</sub> produces the corresponding thiolate\nderivatives <bold>4</bold>\u2013<bold>7</bold> (see Scheme ).</p>", "clean_text": "Substitution reactions have been carried out with complex 1, and therefore, treatment with thiols such as 2-mercaptonicotic acid, 2-thiocytosine, 2-thiouracil, and 6-mercaptopurine in the presence of K2CO3 produces the corresponding thiolate derivatives 4-7 (see Scheme ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 14, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<title>Synthesis of Thiolate Gold Complexes with\nthe Ligand PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc<xref rid=\"sch3-fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr9\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0010.tif\"></graphic>\n<p>\n<fn id=\"sch3-fn1\">\n<label>a</label>\n<p>Legend: (i) 2-mercaptonicotinic\nacid + K<sub>2</sub>CO<sub>3</sub>; (ii) 2-thiocytosine + K<sub>2</sub>CO<sub>3</sub>; (iii) 2-thiouracil + K<sub>2</sub>CO<sub>3</sub>;\n(iv) 2-mercaptopurine + K<sub>2</sub>CO<sub>3</sub>.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 3  Synthesis of Thiolate Gold Complexes with the Ligand PPh2CH2CH2NHCOFc      a Legend: (i) 2-mercaptonicotinic acid + K2CO3; (ii) 2-thiocytosine + K2CO3; (iii) 2-thiouracil + K2CO3; (iv) 2-mercaptopurine + K2CO3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 15, "type": "text", "classification": ["else"], "content": "<p>\n<fn id=\"sch3-fn1\">\n<label>a</label>\n<p>Legend: (i) 2-mercaptonicotinic\nacid + K<sub>2</sub>CO<sub>3</sub>; (ii) 2-thiocytosine + K<sub>2</sub>CO<sub>3</sub>; (iii) 2-thiouracil + K<sub>2</sub>CO<sub>3</sub>;\n(iv) 2-mercaptopurine + K<sub>2</sub>CO<sub>3</sub>.</p>\n</fn>\n</p><p>The NMR data for these complexes agree with the substitution\nof the chlorine ligand for the corresponding thiolate; in the <sup>1</sup>H and <sup>13</sup>C NMR spectra the resonances for both the\namide-phosphine and the thiolate ligands appear. In the <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR the resonance for the phosphorus atom is displaced\ndownfield.</p>", "clean_text": "  a Legend: (i) 2-mercaptonicotinic acid + K2CO3; (ii) 2-thiocytosine + K2CO3; (iii) 2-thiouracil + K2CO3; (iv) 2-mercaptopurine + K2CO3.  \n\nThe NMR data for these complexes agree with the substitution of the chlorine ligand for the corresponding thiolate; in the 1H and 13C NMR spectra the resonances for both the amide-phosphine and the thiolate ligands appear. In the 31P{1H} NMR the resonance for the phosphorus atom is displaced downfield.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 16, "type": "text", "classification": ["else"], "content": "<p>The reaction of ligand <bold>L2</bold> with [AuCl\u00ad(tht)]\nin a 1:2 molar ratio affords the dinuclear gold derivative [Au<sub>2</sub>Cl<sub>2</sub>{(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCOFc}] (<bold>8</bold>). The chloro ligand can be easily\nsubstituted by reactions with thiols such as 2-thiocytosine and 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-<sc>d</sc>-glucopyranosato in the presence of K<sub>2</sub>CO<sub>3</sub> (see Scheme ).</p>", "clean_text": "The reaction of ligand L2 with [AuCl(tht)] in a 1:2 molar ratio affords the dinuclear gold derivative [Au2Cl2{(PPh2CH2CH2)2NCOFc}] (8). The chloro ligand can be easily substituted by reactions with thiols such as 2-thiocytosine and 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-d-glucopyranosato in the presence of K2CO3 (see Scheme ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 17, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<title>Synthesis of Gold\nComplexes with the Ligand (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCOFc<xref rid=\"sch4-fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr10\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0011.tif\"></graphic>\n<p>\n<fn id=\"sch4-fn1\">\n<label>a</label>\n<p>Legend: (i) 2 [AuCl\u00ad(tht)]; (ii)\n2-thiocytosine + K<sub>2</sub>CO<sub>3</sub>; (iii) 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-<sc>d</sc>-glucopyranosato + K<sub>2</sub>CO<sub>3</sub>.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 4  Synthesis of Gold Complexes with the Ligand (PPh2CH2CH2)2NCOFc      a Legend: (i) 2 [AuCl(tht)]; (ii) 2-thiocytosine + K2CO3; (iii) 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-d-glucopyranosato + K2CO3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 18, "type": "text", "classification": "error", "content": "<p>\n<fn id=\"sch4-fn1\">\n<label>a</label>\n<p>Legend: (i) 2 [AuCl\u00ad(tht)]; (ii)\n2-thiocytosine + K<sub>2</sub>CO<sub>3</sub>; (iii) 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-<sc>d</sc>-glucopyranosato + K<sub>2</sub>CO<sub>3</sub>.</p>\n</fn>\n</p><p>The <sup>1</sup>H and <sup>13</sup>C\u00ad{<sup>1</sup>H} spectra\nof complex <bold>8</bold> show all of the resonances arising from\nthe ligand with a different chemical shift after coordination to the\ngold center. The <sup>31</sup>P\u00ad{<sup>1</sup>H} spectrum shows two\nsinglets at 25.7 and 22.2 ppm with a higher chemical shift displacement\nin comparison to the free phosphine. The mass spectrum presents the\nmolecular peak at <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 1117 (45%).\nFor complexes <bold>9</bold> and <bold>10</bold> the <sup>1</sup>H\nand <sup>13</sup>C\u00ad{<sup>1</sup>H} spectra show all of the resonances\narising from the ligand with a different chemical shift after coordination\nto the gold center. The <sup>31</sup>P\u00ad{<sup>1</sup>H} spectra at room\ntemperature show a broad resonance for <bold>9</bold> and two broad\nsinglets for <bold>10</bold>. The low-temperature spectra at \u221285\n\u00b0C for <bold>9</bold> and \u221260 \u00b0C for <bold>10</bold> show the expected two singlets for each compound.</p>", "clean_text": "  a Legend: (i) 2 [AuCl(tht)]; (ii) 2-thiocytosine + K2CO3; (iii) 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-d-glucopyranosato + K2CO3.  \n\nThe 1H and 13C{1H} spectra of complex 8 show all of the resonances arising from the ligand with a different chemical shift after coordination to the gold center. The 31P{1H} spectrum shows two singlets at 25.7 and 22.2 ppm with a higher chemical shift displacement in comparison to the free phosphine. The mass spectrum presents the molecular peak at m/z 1117 (45%). For complexes 9 and 10 the 1H and 13C{1H} spectra show all of the resonances arising from the ligand with a different chemical shift after coordination to the gold center. The 31P{1H} spectra at room temperature show a broad resonance for 9 and two broad singlets for 10. The low-temperature spectra at -85 \u00b0C for 9 and -60 \u00b0C for 10 show the expected two singlets for each compound.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 19, "type": "text", "classification": ["else"], "content": "<p>The molecular\nstructure of complex <bold>8</bold> has been established by X-ray\ndiffraction, and the molecule is shown in Figure . The gold\u00ad(I) centers are linearly coordinated with angles\nP(1)\u2013Au(1)\u2013Cl(1) = 174.35(9)\u00b0 and P(2)\u2013Au(2)\u2013Cl(2)\n= 173.17(9)\u00b0. The Au\u2013P distances are 2.232(2) and 2.228(2)\n\u00c5, and the Au\u2013Cl distances are 2.294(2) and 2.292(2) \u00c5,\nwhich are similar to those found in complexes such as [Au<sub>2</sub>Cl<sub>2</sub>(dppf)].\n</p>", "clean_text": "The molecular structure of complex 8 has been established by X-ray diffraction, and the molecule is shown in Figure . The gold(I) centers are linearly coordinated with angles P(1)-Au(1)-Cl(1) = 174.35(9)\u00b0 and P(2)-Au(2)-Cl(2) = 173.17(9)\u00b0. The Au-P distances are 2.232(2) and 2.228(2) \u00c5, and the Au-Cl distances are 2.294(2) and 2.292(2) \u00c5, which are similar to those found in complexes such as [Au2Cl2(dppf)]. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 20, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Molecular structure for\ncompound <bold>8</bold> with 50% probability ellipsoids. Hydrogen\natoms are omitted for clarity. Selected bond lengths (\u00c5) and\nangles (deg): Au(1)\u2013P(1) = 2.233(2), Au(1)\u2013Cl(1) = 2.294(2),\nAu(2)\u2013P(2) = 2.228(2), Au(2)\u2013Cl(2) = 2.292(2); P(1)\u2013Au(1)\u2013Cl(1)\n= 174.35(9), P(2)\u2013Au(2)\u2013Cl(2) = 173.17(9).</p>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0003.tif\"></graphic>\n</fig>", "clean_text": " 1  Molecular structure for compound 8 with 50% probability ellipsoids. Hydrogen atoms are omitted for clarity. Selected bond lengths (\u00c5) and angles (deg): Au(1)-P(1) = 2.233(2), Au(1)-Cl(1) = 2.294(2), Au(2)-P(2) = 2.228(2), Au(2)-Cl(2) = 2.292(2); P(1)-Au(1)-Cl(1) = 174.35(9), P(2)-Au(2)-Cl(2) = 173.17(9).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 21, "type": "text", "classification": ["else"], "content": "<p>In the crystal the molecules associated through\nintermolecular aurophilic interactions of 3.2816(5) \u00c5, forming\na chain polymer (see Figure ).</p><p>The reaction of the ligand <bold>L3</bold> or dppf with [AuCl\u00ad(tht)] (molar ratio 1:2) gives the dinuclear\ngold derivative [Au<sub>2</sub>Cl<sub>2</sub>{(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCO)<sub>2</sub>Fc}] or [Au<sub>2</sub>Cl<sub>2</sub>(dppf)], previously reported by us. These complexes further react with thiols such as 2-thiocytosine,\n2-thiouracil, and 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-<sc>d</sc>-glucopyranosato (HTG) in the presence of K<sub>2</sub>CO<sub>3</sub> to afford the thiolate gold species (see Figure ).</p>", "clean_text": "In the crystal the molecules associated through intermolecular aurophilic interactions of 3.2816(5) \u00c5, forming a chain polymer (see Figure ).\n\nThe reaction of the ligand L3 or dppf with [AuCl(tht)] (molar ratio 1:2) gives the dinuclear gold derivative [Au2Cl2{(PPh2CH2CH2NHCO)2Fc}] or [Au2Cl2(dppf)], previously reported by us. These complexes further react with thiols such as 2-thiocytosine, 2-thiouracil, and 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-d-glucopyranosato (HTG) in the presence of K2CO3 to afford the thiolate gold species (see Figure ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 22, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Polymer chain of complex <bold>8</bold> though intermolecular aurophilic interactions. Selected\nbond lengths (\u00c5) and angles (deg): Au(1)\u2013Au(2) = 3.2816(5);\nP(1)\u2013Au(1)\u2013Au(2) = 110.76(6), P(2)\u2013Au(2)\u2013Au(1)\n= 91.64(6).</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0004.tif\"></graphic>\n</fig>", "clean_text": " 2  Polymer chain of complex 8 though intermolecular aurophilic interactions. Selected bond lengths (\u00c5) and angles (deg): Au(1)-Au(2) = 3.2816(5); P(1)-Au(1)-Au(2) = 110.76(6), P(2)-Au(2)-Au(1) = 91.64(6).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Thiolate gold complexes prepared from <bold>L3</bold> and dppf.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0005.tif\"></graphic>\n</fig>", "clean_text": " 3  Thiolate gold complexes prepared from L3 and dppf.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 24, "type": "text", "classification": ["else"], "content": "<p>The <sup>1</sup>H NMR spectra\nof complexes <bold>11</bold>\u2013<bold>14</bold> show the resonances\nfor the disubstituted ferrocene as two multiplets for the equivalent\n\u03b1 and \u03b2 protons of both cyclopentadienyl groups, two multiplets\nfor the methylene protons in complexes <bold>11</bold> and <bold>12</bold>, and resonances arising from the phenyl protons and the corresponding\nthiolate ligand. The <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR spectra present\na unique resonance in all cases, corresponding to equivalent phosphorus\natoms.</p>", "clean_text": "The 1H NMR spectra of complexes 11-14 show the resonances for the disubstituted ferrocene as two multiplets for the equivalent \u03b1 and \u03b2 protons of both cyclopentadienyl groups, two multiplets for the methylene protons in complexes 11 and 12, and resonances arising from the phenyl protons and the corresponding thiolate ligand. The 31P{1H} NMR spectra present a unique resonance in all cases, corresponding to equivalent phosphorus atoms.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 25, "type": "text", "classification": "error", "content": "<p>The structure of complex <bold>13</bold> has been established\nby X-ray diffraction studies, and the molecule is shown in Figure . The compound crystallizes in the orthorhombic\nnoncentrosymmetric <italic toggle=\"yes\">P</italic>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> space group. The molecule is chiral, and the original configuration\nof the <sc>d</sc> isomer (2<italic toggle=\"yes\">R</italic>,3<italic toggle=\"yes\">R</italic>,4<italic toggle=\"yes\">S</italic>,5<italic toggle=\"yes\">R</italic>,6<italic toggle=\"yes\">R</italic>) is retained.\nThe gold centers are found in a linear geometry with angles of 177.81(15)\nand 177.44(16) \u00c5. The Au\u2013S bond distances are 2.319(5)\nand 2.301(4) \u00c5, and the Au\u2013P distances are 2.280(4) and\n2.266(4) \u00c5, which are on the same order as those found in thiolate\ngold phosphine complexes. The ferrocenyl rings are planar and adopt\na rotated anticlinal conformation.</p>", "clean_text": "The structure of complex 13 has been established by X-ray diffraction studies, and the molecule is shown in Figure . The compound crystallizes in the orthorhombic noncentrosymmetric P212121 space group. The molecule is chiral, and the original configuration of the d isomer (2R,3R,4S,5R,6R) is retained. The gold centers are found in a linear geometry with angles of 177.81(15) and 177.44(16) \u00c5. The Au-S bond distances are 2.319(5) and 2.301(4) \u00c5, and the Au-P distances are 2.280(4) and 2.266(4) \u00c5, which are on the same order as those found in thiolate gold phosphine complexes. The ferrocenyl rings are planar and adopt a rotated anticlinal conformation.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Molecular structure of complex <bold>13</bold> with atom-labeling scheme. Hydrogen atoms have been omitted. Radii\nare arbritrary. Selected bond lengths (\u00c5) and angles (deg): Au(1)\u2013P(1)\n= 2.280(4), Au(1)\u2013S(1) = 2.319(5), Au(2)\u2013P(2)#1 = 2.266(4),\nAu(2)\u2013S(2) = 2.301(4); P(2)#1\u2013Au(2)\u2013S(2) = 177.44(16),\nP(2)#1\u2013Au(2)\u2013Au(1) = 104.31(8). Symmetry transformation:\n(#1) \u2212<italic toggle=\"yes\">x</italic> + <sup>1</sup>/<sub>2</sub>, \u2212<italic toggle=\"yes\">y</italic> + 2, <italic toggle=\"yes\">z</italic> + <sup>1</sup>/<sub>2</sub>.</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0006.tif\"></graphic>\n</fig>", "clean_text": " 4  Molecular structure of complex 13 with atom-labeling scheme. Hydrogen atoms have been omitted. Radii are arbritrary. Selected bond lengths (\u00c5) and angles (deg): Au(1)-P(1) = 2.280(4), Au(1)-S(1) = 2.319(5), Au(2)-P(2)#1 = 2.266(4), Au(2)-S(2) = 2.301(4); P(2)#1-Au(2)-S(2) = 177.44(16), P(2)#1-Au(2)-Au(1) = 104.31(8). Symmetry transformation: (#1) -x + 1/2, -y + 2, z + 1/2.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "text", "classification": ["else"], "content": "<p>In the structure short intermolecular\naurophilic interactions of 3.010(3) \u00c5 are observed (see Figure ), and a polymeric chain is formed, in a way similar\nto that for complex <bold>8</bold>. There are also several secondary\nbonds between the oxygen atoms of the thiolate and some of the protons\nthat can be considered as hydrogen bonds, the shortest being C(45)\u2013H(45)\u00b7\u00b7\u00b7O(9)#3\n(symmetry transformation: (#3) <italic toggle=\"yes\">x</italic> + <sup>1</sup>/<sub>2</sub>, \u2212<italic toggle=\"yes\">y</italic> + <sup>3</sup>/<sub>2</sub>,\n\u2212<italic toggle=\"yes\">z</italic> + 1) of 2.33 \u00c5, with an angle of 156.6\u00b0.</p>", "clean_text": "In the structure short intermolecular aurophilic interactions of 3.010(3) \u00c5 are observed (see Figure ), and a polymeric chain is formed, in a way similar to that for complex 8. There are also several secondary bonds between the oxygen atoms of the thiolate and some of the protons that can be considered as hydrogen bonds, the shortest being C(45)-H(45)\u22c5\u22c5\u22c5O(9)#3 (symmetry transformation: (#3) x + 1/2, -y + 3/2, -z + 1) of 2.33 \u00c5, with an angle of 156.6\u00b0.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 28, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Formation\nof a polymer chain through aurophilic interactions. Selected bond\nlengths (\u00c5) and angles (deg): Au(1)\u2013Au(2) = 3.010(3);\nP(1)\u2013Au(1)\u2013Au(2) = 97.61(9), S(1)\u2013Au(1)\u2013Au(2)\n= 80.92(10), P(2)#1\u2013Au(2)\u2013Au(1) = 104.31(8), S(2)\u2013Au(2)\u2013Au(1)\n= 75.74(9). Symmetry transformation: (#1) \u2212<italic toggle=\"yes\">x</italic> + <sup>1</sup>/<sub>2</sub>, \u2212<italic toggle=\"yes\">y</italic> + 2, <italic toggle=\"yes\">z</italic> + <sup>1</sup>/<sub>2</sub>.</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0007.tif\"></graphic>\n</fig>", "clean_text": " 5  Formation of a polymer chain through aurophilic interactions. Selected bond lengths (\u00c5) and angles (deg): Au(1)-Au(2) = 3.010(3); P(1)-Au(1)-Au(2) = 97.61(9), S(1)-Au(1)-Au(2) = 80.92(10), P(2)#1-Au(2)-Au(1) = 104.31(8), S(2)-Au(2)-Au(1) = 75.74(9). Symmetry transformation: (#1) -x + 1/2, -y + 2, z + 1/2.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 29, "type": "text", "classification": ["else"], "content": "<title>Biological Evaluation</title><p>The ferrocenyl-amide phosphine ligands\nand the complexes synthesized with them were tested for cytotoxicity\nagainst four tumor cell lines: the two murine cell lines NIH-3T3 (mouse\nembryonic fibroblasts) and PC-12 (pheochromocytoma of the rat adrenal\nmedulla) and the two human cell lines A-549 (adenocarcinomic human\nalveolar basal epithelial cells) and Hep-G2 (hepatocellular carcinoma).</p>", "clean_text": "Biological Evaluation\n\nThe ferrocenyl-amide phosphine ligands and the complexes synthesized with them were tested for cytotoxicity against four tumor cell lines: the two murine cell lines NIH-3T3 (mouse embryonic fibroblasts) and PC-12 (pheochromocytoma of the rat adrenal medulla) and the two human cell lines A-549 (adenocarcinomic human alveolar basal epithelial cells) and Hep-G2 (hepatocellular carcinoma).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 30, "type": "text", "classification": ["else"], "content": "<p>Cells were exposed to each compound for a total of 48 h. Using\nthe calorimetric mitochondrial function-based MTT viability assay,\nthe IC<sub>50</sub> values (final concentration \u22640.5% DMSO)\nwere calculated from dose\u2013response curves obtained by nonlinear\nregression analysis. IC<sub>50</sub> values are concentrations of\ndrugs required to inhibit tumor cell proliferation by 50% in comparison\nto the control viability.</p>", "clean_text": "Cells were exposed to each compound for a total of 48 h. Using the calorimetric mitochondrial function-based MTT viability assay, the IC50 values (final concentration \u22640.5% DMSO) were calculated from dose-response curves obtained by nonlinear regression analysis. IC50 values are concentrations of drugs required to inhibit tumor cell proliferation by 50% in comparison to the control viability.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 31, "type": "text", "classification": "error", "content": "<p>As demonstrated by the IC<sub>50</sub> values collected in Table , neither of the\nligands <bold>L1</bold> and <bold>L2</bold> showed significant antiproliferative\nactivity. For the gold chloride and silver complexes higher cytotoxic\nactivity is found for the chloro-gold compounds, for which the smallest\nvalues are found for [AuCl\u00ad(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc)] (<bold>1</bold>) in the murine cells, with a very low value\nfor NIH-3T3 cells of 0.1 \u03bcM, and for the previously reported\n[Au<sub>2</sub>Cl<sub>2</sub>(\u03bc-dppf)] in the human cell lines\nwith values of 8.2 and 10.7 \u03bcM. The silver complexes <bold>2</bold> and <bold>3</bold> have only a moderate activity in all of the cell\nlines.</p>", "clean_text": "As demonstrated by the IC50 values collected in Table , neither of the ligands L1 and L2 showed significant antiproliferative activity. For the gold chloride and silver complexes higher cytotoxic activity is found for the chloro-gold compounds, for which the smallest values are found for [AuCl(PPh2CH2CH2NHCOFc)] (1) in the murine cells, with a very low value for NIH-3T3 cells of 0.1 \u03bcM, and for the previously reported [Au2Cl2(\u03bc-dppf)] in the human cell lines with values of 8.2 and 10.7 \u03bcM. The silver complexes 2 and 3 have only a moderate activity in all of the cell lines.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 32, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\" nameend=\"col5\" namest=\"col2\" rowsep=\"1\">IC<sub>50</sub> (\u03bcM)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry align=\"center\">compd</oasis:entry>\n<oasis:entry align=\"center\">NIH-3T3</oasis:entry>\n<oasis:entry align=\"center\">PC-12</oasis:entry>\n<oasis:entry align=\"center\">A-549</oasis:entry>\n<oasis:entry align=\"center\">Hep-G2</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>L1</bold>\n</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L2</bold>\n</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>0.1</oasis:entry>\n<oasis:entry>4.2</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>68</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry>23.3</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>21</oasis:entry>\n<oasis:entry>70.7</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>42.3</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>26.4</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>8</bold>\n</oasis:entry>\n<oasis:entry>11.4</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>29.9</oasis:entry>\n<oasis:entry>29.1</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>[Au<sub>2</sub>Cl<sub>2</sub>(\u03bc-<bold>L3</bold>)]</oasis:entry>\n<oasis:entry>14.5</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>[Au<sub>2</sub>Cl<sub>2</sub>(\u03bc-dppf)]</oasis:entry>\n<oasis:entry>9.8</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>8.2</oasis:entry>\n<oasis:entry>10.7</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 33, "type": "text", "classification": "error", "content": "<p>The antiproliferative\nactivity of all the thiolate gold derivatives of <bold>L1</bold>\u2013<bold>L3</bold> and dppf have been measured under the same conditions (Table ). The general observation is that very good values\nfor the activity are found in the murine cell lines NIH-3T3 and PC-12\nand moderate to good values are found in the human cell lines A-549\nand Hep-G2. For the murine cell lines lower values are found for the\ngold thiolates of <bold>L1</bold>, with the nicotinic acid thiolate\n(<bold>4</bold>), thiocytosine (<bold>5</bold>), and thiouracil (<bold>6</bold>), with values even lower than those for auranofin. Surprisingly\nthe values for the purine thiolate are higher, although this thiol\nhas biological activity by itself. For the human cell lines the best\nvalues are found for compound <bold>4</bold>, [Au\u00ad(SNic)\u00ad(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc)] (SNic = thionicotinic acid),\nagain with <bold>L1</bold> and the thioniconitic acid, and for the\ndppf derivatives. In all the cases the activity obtained with the\nthiolate ligands is much higher than that for the corresponding chloro\nderivatives with the same amide-phosphine ligand, with the exception\nof the diphosphine dppf, which possesses similar values among chloro\nor thiolate as auxiliary ligands. These values are always higher than\nthose obtained for auranofin but much lower than those for cisplatin.</p>", "clean_text": "The antiproliferative activity of all the thiolate gold derivatives of L1-L3 and dppf have been measured under the same conditions (Table ). The general observation is that very good values for the activity are found in the murine cell lines NIH-3T3 and PC-12 and moderate to good values are found in the human cell lines A-549 and Hep-G2. For the murine cell lines lower values are found for the gold thiolates of L1, with the nicotinic acid thiolate (4), thiocytosine (5), and thiouracil (6), with values even lower than those for auranofin. Surprisingly the values for the purine thiolate are higher, although this thiol has biological activity by itself. For the human cell lines the best values are found for compound 4, [Au(SNic)(PPh2CH2CH2NHCOFc)] (SNic = thionicotinic acid), again with L1 and the thioniconitic acid, and for the dppf derivatives. In all the cases the activity obtained with the thiolate ligands is much higher than that for the corresponding chloro derivatives with the same amide-phosphine ligand, with the exception of the diphosphine dppf, which possesses similar values among chloro or thiolate as auxiliary ligands. These values are always higher than those obtained for auranofin but much lower than those for cisplatin.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 34, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\" nameend=\"col5\" namest=\"col2\" rowsep=\"1\">IC<sub>50</sub> (\u03bcM)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry align=\"center\" valign=\"top\">compd</oasis:entry>\n<oasis:entry align=\"center\" valign=\"top\">NIH-3T3</oasis:entry>\n<oasis:entry align=\"center\" valign=\"top\">PC-12</oasis:entry>\n<oasis:entry align=\"center\" valign=\"top\">A-549</oasis:entry>\n<oasis:entry align=\"center\" valign=\"top\">Hep-G2</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>0.2</oasis:entry>\n<oasis:entry>2.1</oasis:entry>\n<oasis:entry>12.6</oasis:entry>\n<oasis:entry>7.8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>5</bold>\n</oasis:entry>\n<oasis:entry>0.8</oasis:entry>\n<oasis:entry>2.4</oasis:entry>\n<oasis:entry>95.1</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>6</bold>\n</oasis:entry>\n<oasis:entry>2.0</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>15.0</oasis:entry>\n<oasis:entry>20.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>7</bold>\n</oasis:entry>\n<oasis:entry>13.7</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>21.0</oasis:entry>\n<oasis:entry>70.7</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>9</bold>\n</oasis:entry>\n<oasis:entry>4.7</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>13.1</oasis:entry>\n<oasis:entry>12.4</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>10</bold>\n</oasis:entry>\n<oasis:entry>4.0</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>14.5</oasis:entry>\n<oasis:entry>11.1</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>11</bold>\n</oasis:entry>\n<oasis:entry>5.4</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>30.3</oasis:entry>\n<oasis:entry>17.6</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>12</bold>\n</oasis:entry>\n<oasis:entry>14.7</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>74.9</oasis:entry>\n<oasis:entry>72.9</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>13</bold>\n</oasis:entry>\n<oasis:entry>5.9</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>7.0</oasis:entry>\n<oasis:entry>13.7</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>14</bold>\n</oasis:entry>\n<oasis:entry>5.4</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>12.0</oasis:entry>\n<oasis:entry>14.8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>auranofin</oasis:entry>\n<oasis:entry>2.5</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>3.4</oasis:entry>\n<oasis:entry>2.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>cisplatin</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>29.2</oasis:entry>\n<oasis:entry>15</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 35, "type": "text", "classification": "error", "content": "<p>With all these data it is not easy to establish a\nstructure\u2013activity relationship. It seems that among the ferrocenyl\namide phosphines good to excellent values are found for the complexes\nwith the monosubstituted ferrocenyl phosphines, and with the monophosphine <bold>L1</bold> excellent values are found in the murine cells for all\nof the complexes, but only for the nicotinic acid thiolate in the\nhuman cell lines. However, compounds with the monosubstituted ferrocenyl\ndiphosphine ligand <bold>L2</bold> have good values in all of the\ncell lines. The complexes with the disubstituted ferrocenyl amide\ndiphosphine (<bold>L3</bold>) present the poorest antiproliferative\nvalues. The IC<sub>50</sub> values for the complexes with dppf are\ngood but are of the same order as that of the complexes with <bold>L2</bold>.</p>", "clean_text": "With all these data it is not easy to establish a structure-activity relationship. It seems that among the ferrocenyl amide phosphines good to excellent values are found for the complexes with the monosubstituted ferrocenyl phosphines, and with the monophosphine L1 excellent values are found in the murine cells for all of the complexes, but only for the nicotinic acid thiolate in the human cell lines. However, compounds with the monosubstituted ferrocenyl diphosphine ligand L2 have good values in all of the cell lines. The complexes with the disubstituted ferrocenyl amide diphosphine (L3) present the poorest antiproliferative values. The IC50 values for the complexes with dppf are good but are of the same order as that of the complexes with L2.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 36, "type": "text", "classification": "error", "content": "<title>Conclusions</title><p>Several ferrocenyl amide\nphosphines such as PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc\n(<bold>L1</bold>), (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCOFc (<bold>L2</bold>), and (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCO)<sub>2</sub>Fc (<bold>L3</bold>) have been chosen\nin order to prepare different gold\u00ad(I) and silver\u00ad(I) complexes and\nmeasure their antiproliferative activities. As a comparison, complexes\nwith the well-known dppf ligand have been prepared. The gold chloride\nderivatives [AuCl\u00ad(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc)],\n[Au<sub>2</sub>Cl<sub>2</sub>{(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCOFc}], and [Au<sub>2</sub>Cl<sub>2</sub>{(PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCO)<sub>2</sub>Fc}] have been\nsynthesized in which the chloro ligand can be easily substituted by\nseveral biologically relevant thiolates such as 2-mercaptonicotinic\nacid, 2-thiocytosine, 2-thiouracil, 2-mercaptopurine, and 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-<sc>d</sc>-glucopyranosato, affording the gold phosphine thiolate species.\nThe antiproliferative activity of these compounds have been tested\nby the MTT viability assay in two murine cell lines, NIH-3T3 (mouse\nembryonic fibroblasts) and PC-12 (pheochromocytoma of the rat adrenal\nmedulla), and two human cell lines, A-549 (adenocarcinomic human alveolar\nbasal epithelial cells) and Hep-G2 (hepatocellular carcinoma). The\nferrocenyl amide phosphine ligands are not active, whereas the metal\ncomplexes are. The silver complexes are less active than the gold\nspecies. Among the ferrocenyl amide phosphines good to excellent values\nare found for the gold complexes with the monosubstituted ferrocenyl\nphosphines. With the monophosphine <bold>L1</bold> excellent values\nare found in the murine cells for all the complexes, but only for\nthe nicotinic acid thiolate species in the human cell lines. However,\nthe complexes with the monosubstituted ferrocenyl diphosphine ligand <bold>L2</bold> have good values in all the cell lines. The complexes with\nthe disubstituted ferrocenyl amide diphosphine (<bold>L3</bold>) present\nthe poorest antiproliferative values. The IC<sub>50</sub> values for\nthe compounds with dppf are good but are of the same order as those\nwith <bold>L2</bold>.</p>", "clean_text": "Conclusions\n\nSeveral ferrocenyl amide phosphines such as PPh2CH2CH2NHCOFc (L1), (PPh2CH2CH2)2NCOFc (L2), and (PPh2CH2CH2NHCO)2Fc (L3) have been chosen in order to prepare different gold(I) and silver(I) complexes and measure their antiproliferative activities. As a comparison, complexes with the well-known dppf ligand have been prepared. The gold chloride derivatives [AuCl(PPh2CH2CH2NHCOFc)], [Au2Cl2{(PPh2CH2CH2)2NCOFc}], and [Au2Cl2{(PPh2CH2CH2NHCO)2Fc}] have been synthesized in which the chloro ligand can be easily substituted by several biologically relevant thiolates such as 2-mercaptonicotinic acid, 2-thiocytosine, 2-thiouracil, 2-mercaptopurine, and 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-d-glucopyranosato, affording the gold phosphine thiolate species. The antiproliferative activity of these compounds have been tested by the MTT viability assay in two murine cell lines, NIH-3T3 (mouse embryonic fibroblasts) and PC-12 (pheochromocytoma of the rat adrenal medulla), and two human cell lines, A-549 (adenocarcinomic human alveolar basal epithelial cells) and Hep-G2 (hepatocellular carcinoma). The ferrocenyl amide phosphine ligands are not active, whereas the metal complexes are. The silver complexes are less active than the gold species. Among the ferrocenyl amide phosphines good to excellent values are found for the gold complexes with the monosubstituted ferrocenyl phosphines. With the monophosphine L1 excellent values are found in the murine cells for all the complexes, but only for the nicotinic acid thiolate species in the human cell lines. However, the complexes with the monosubstituted ferrocenyl diphosphine ligand L2 have good values in all the cell lines. The complexes with the disubstituted ferrocenyl amide diphosphine (L3) present the poorest antiproliferative values. The IC50 values for the compounds with dppf are good but are of the same order as those with L2.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 37, "type": "text", "classification": ["else"], "content": "<title>Experimental Section</title><title>Instrumentation</title><p>C, H, and N analysis were carried out with a Perkin-Elmer 2400\nmicroanalyzer. Mass spectra were recorded on a Bruker Esquire 3000\nPlus instrument, with the electrospray (ESI) technique, and on a Bruker\nMicroflex (MALDI-TOF) instrument. <sup>1</sup>H, <sup>13</sup>C\u00ad{<sup>1</sup>H}, and <sup>19</sup>F NMR spectra, including 2D experiments,\nwere recorded at room temperature on a Bruker Avance 400 spectrometer\n(<sup>1</sup>H, 400 MHz; <sup>13</sup>C, 100.6 MHz; <sup>19</sup>F,\n376.5 MHz) or on a Bruker Avance II 300 spectrometer (<sup>1</sup>H, 300 MHz; <sup>13</sup>C, 75.5 MHz; <sup>19</sup>F, 282.3 MHz),\nwith chemical shifts (\u03b4, ppm) reported relative to the solvent\npeaks of the deuterated solvent.\n</p>", "clean_text": "Experimental Section\n\nInstrumentation\n\nC, H, and N analysis were carried out with a Perkin-Elmer 2400 microanalyzer. Mass spectra were recorded on a Bruker Esquire 3000 Plus instrument, with the electrospray (ESI) technique, and on a Bruker Microflex (MALDI-TOF) instrument. 1H, 13C{1H}, and 19F NMR spectra, including 2D experiments, were recorded at room temperature on a Bruker Avance 400 spectrometer (1H, 400 MHz; 13C, 100.6 MHz; 19F, 376.5 MHz) or on a Bruker Avance II 300 spectrometer (1H, 300 MHz; 13C, 75.5 MHz; 19F, 282.3 MHz), with chemical shifts (\u03b4, ppm) reported relative to the solvent peaks of the deuterated solvent. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 38, "type": "text", "classification": ["else"], "content": "<title>Starting\nMaterials</title><p>The starting materials FcCOCl, (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCO)<sub>2</sub>Fc, [AuCl\u00ad(tht)], and [Ag\u00ad(OTf)\u00ad(PPh<sub>3</sub>)] were prepared according to published procedures. All other reagents\nwere commercially available. Solvents were used as received without\npurification or drying or dried with a SPS solvent purification system.</p>", "clean_text": "Starting Materials\n\nThe starting materials FcCOCl, (PPh2CH2CH2NHCO)2Fc, [AuCl(tht)], and [Ag(OTf)(PPh3)] were prepared according to published procedures. All other reagents were commercially available. Solvents were used as received without purification or drying or dried with a SPS solvent purification system.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 39, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc (<bold>L1</bold>)</title><p>To a solution of 2-(diphenylphosphino)\u00adethylamine\n(46 \u03bcL, 0.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was\nadded triethylamine (60 \u03bcL, 0.43 mmol); the solution was stirred\nfor 10 min at room temperature, and then it was poured into an ice\nbath, a solution of chlorocarbonylferrocene in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added dropwise, and the mixture was stirred overnight.\nAn aqueous solution of NaHCO<sub>3</sub> (30 mL) was added, the two\nphases were separated, and anhydrous Na<sub>2</sub>SO<sub>4</sub> was\nadded to the organic phase for drying. The solvent was evaporated\nto ca. 5 mL, and hexane (20 mL) was added to obtain a yellow solid:\n75% yield (0.066 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4\n(ppm): 7.47 (m, 4H, Ph), 7.36 (m, 6H, Ph), 5.92 (m, br, 1H, NH), 4.58\n(m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.31 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.19 (s, 5H, Cp), 3.54 (m, 2H, \u2212CH<sub>2</sub>N\u2212), 2.40 (t, <italic toggle=\"yes\">J</italic> = 7.1 Hz, 2H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 170.34 (C\ue5fbO), 137.70 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.4 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 132.91 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 18.7 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 129.07 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>),\n128.82 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 6.9\nHz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 76.15 (C<sub>ipso</sub>), 70.48, 68.18 (C<sub>5</sub>H<sub>4</sub>), 69.89 (Cp), 36.99 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sup>\n<italic toggle=\"yes\"></italic>\n</sup>\n<sub>C\u2013P</sub> = 18.8 Hz, \u2212CH<sub>2</sub>N\u2212), 28.93 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sup>\n<italic toggle=\"yes\"></italic>\n</sup>\n<sub>C\u2013P</sub> = 12.6 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): \u221220.93. MS\n(FAB<sup>+</sup>): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 442 (100%).\nAnal. Calcd for C<sub>25</sub>H<sub>24</sub>FeNOP (441.3): C, 68.04;\nH, 5.48; N, 3.17. Found: C, 67.82; H, 5.45; N, 3.29.</p>", "clean_text": "Synthesis of PPh2CH2CH2NHCOFc (L1)\n\nTo a solution of 2-(diphenylphosphino)ethylamine (46 \u03bcL, 0.2 mmol) in CH2Cl2 (20 mL) was added triethylamine (60 \u03bcL, 0.43 mmol); the solution was stirred for 10 min at room temperature, and then it was poured into an ice bath, a solution of chlorocarbonylferrocene in CH2Cl2 (20 mL) was added dropwise, and the mixture was stirred overnight. An aqueous solution of NaHCO3 (30 mL) was added, the two phases were separated, and anhydrous Na2SO4 was added to the organic phase for drying. The solvent was evaporated to ca. 5 mL, and hexane (20 mL) was added to obtain a yellow solid: 75% yield (0.066 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.47 (m, 4H, Ph), 7.36 (m, 6H, Ph), 5.92 (m, br, 1H, NH), 4.58 (m, 2H, \u03b2-C5H4), 4.31 (m, 2H, \u03b1-C5H4), 4.19 (s, 5H, Cp), 3.54 (m, 2H, -CH2N-), 2.40 (t, J = 7.1 Hz, 2H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 170.34 (C\ue5fbO), 137.70 (d, 1 J P-C = 11.4 Hz, ipso-C6H5), 132.91 (d, 2 J P-C = 18.7 Hz, o-C6H5), 129.07 (p-C6H5), 128.82 (d, 3 J P-C = 6.9 Hz, m-C6H5), 76.15 (Cipso), 70.48, 68.18 (C5H4), 69.89 (Cp), 36.99 (d, 2 J    C-P = 18.8 Hz, -CH2N-), 28.93 (d, 1 J    C-P = 12.6 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): -20.93. MS (FAB+): m/z 442 (100%). Anal. Calcd for C25H24FeNOP (441.3): C, 68.04; H, 5.48; N, 3.17. Found: C, 67.82; H, 5.45; N, 3.29.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 40, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis\nof (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCOFc\n(<bold>L2</bold>)</title><p>To a solution of bis\u00ad[2-(diphenylphosphino)\u00adethyl]\u00adamine\n(0.4777 g, 1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added\ntriethylamine (300 \u03bcL, 2.1 mmol); the solution was stirred for\n10 min at room temperature and then poured into an ice bath, a solution\nof chlorocarbonylferrocene in CH<sub>2</sub>Cl<sub>2</sub> (20 mL)\nwas added dropwise, and the mixture was then stirred overnight. An\naqueous solution of NaHCO<sub>3</sub> (30 mL) was added, the two phases\nwere separated, and anhydrous Na<sub>2</sub>SO<sub>4</sub> was added\nto the organic phase. The solvent was evaporated to ca. 15 mL, and\nhexane (40 mL) was added to obtain a white solid: 85% yield (0.555\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.38 (m, 20H),\n4.37 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.18 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.13 (s, 5H, Cp), 3.51 (m, 4H, \u2212CH<sub>2</sub>N\u2212), 2.33 (m, 4H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 170.33\n(C\ue5fbO), 132.88 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 18.8 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 128.77\n(d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 6.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 70.43, 69.77 (C<sub>5</sub>H<sub>4</sub>), 69.84 (Cp). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): \u221220.11, \u221221.54. MS (FAB<sup>+</sup>): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 654 (50%). Anal.\nCalcd for C<sub>39</sub>H<sub>37</sub>FeNOP<sub>2</sub> (653.5): C,\n71.68; H, 5.71; N, 2.14. Found: C, 71.76; H, 5.27; N, 1.96.</p>", "clean_text": "Synthesis of (PPh2CH2CH2)2NCOFc (L2)\n\nTo a solution of bis[2-(diphenylphosphino)ethyl]amine (0.4777 g, 1 mmol) in CH2Cl2 (50 mL) was added triethylamine (300 \u03bcL, 2.1 mmol); the solution was stirred for 10 min at room temperature and then poured into an ice bath, a solution of chlorocarbonylferrocene in CH2Cl2 (20 mL) was added dropwise, and the mixture was then stirred overnight. An aqueous solution of NaHCO3 (30 mL) was added, the two phases were separated, and anhydrous Na2SO4 was added to the organic phase. The solvent was evaporated to ca. 15 mL, and hexane (40 mL) was added to obtain a white solid: 85% yield (0.555 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.38 (m, 20H), 4.37 (m, 2H, \u03b2-C5H4), 4.18 (m, 2H, \u03b1-C5H4), 4.13 (s, 5H, Cp), 3.51 (m, 4H, -CH2N-), 2.33 (m, 4H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 170.33 (C\ue5fbO), 132.88 (d, 2 J P-C = 18.8 Hz, o-C6H5), 128.77 (d, 3 J P-C = 6.4 Hz, m-C6H5), 70.43, 69.77 (C5H4), 69.84 (Cp). 31P{1H} NMR (CDCl3) \u03b4 (ppm): -20.11, -21.54. MS (FAB+): m/z 654 (50%). Anal. Calcd for C39H37FeNOP2 (653.5): C, 71.68; H, 5.71; N, 2.14. Found: C, 71.76; H, 5.27; N, 1.96.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 41, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis\nof [AuCl\u00ad(<bold>L1</bold>)] (<bold>1</bold>)</title><p>To a solution\nof <bold>L1</bold> (0.066 g, 0.15 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added [AuCl\u00ad(tht)] (0.048 g, 0.15 mmol), and the mixture\nwas stirred for 1 h. Then, the solution was evaporated to ca. 5 mL\nand hexane (15 mL) was added to obtain a yellow solid: 88% yield (0.088\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.71 (m, 4H,\nPh), 7.48 (m, 6H, Ph), 6.23 (m, br, 1H, NH), 4.67 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.37 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.21 (s, 5H, Cp), 3.68 (m, br, 2H, \u2212CH<sub>2</sub>N\u2212),\n2.87 (m, br, 2H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.21 (C\ue5fbO),\n133.34 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.3\nHz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 132.37 (<italic toggle=\"yes\">p</italic>-C<sub>5</sub>H<sub>6</sub>), 129.63 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.7 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 128.76 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 61.7 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 75.13 (C<sub>ipso</sub>), 70.95, 68.39 (C<sub>5</sub>H<sub>4</sub>), 69.90 (Cp), 36.38 (d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 5.6 Hz, \u2212CH<sub>2</sub>N\u2212), 28.72 (d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 37.7 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 24.32.\nMS (FAB<sup>+</sup>): [M]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 673 (48.18%), [M \u2013 Cl]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 638 (100%). Anal. Calcd for C<sub>25</sub>H<sub>24</sub>AuClFeNOP (673.7): C, 44.57; H, 3.59; N, 2.08. Found C, 44.73; H,\n3.54; N, 2.19.</p>", "clean_text": "Synthesis of [AuCl(L1)] (1)\n\nTo a solution of L1 (0.066 g, 0.15 mmol) in CH2Cl2 (20 mL) was added [AuCl(tht)] (0.048 g, 0.15 mmol), and the mixture was stirred for 1 h. Then, the solution was evaporated to ca. 5 mL and hexane (15 mL) was added to obtain a yellow solid: 88% yield (0.088 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.71 (m, 4H, Ph), 7.48 (m, 6H, Ph), 6.23 (m, br, 1H, NH), 4.67 (m, 2H, \u03b2-C5H4), 4.37 (m, 2H, \u03b1-C5H4), 4.21 (s, 5H, Cp), 3.68 (m, br, 2H, -CH2N-), 2.87 (m, br, 2H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.21 (C\ue5fbO), 133.34 (d, 2 J P-C = 13.3 Hz, o-C6H5), 132.37 (p-C5H6), 129.63 (d, 3 J P-C = 11.7 Hz, m-C6H5), 128.76 (d, 1 J P-C = 61.7 Hz, ipso-C6H5), 75.13 (Cipso), 70.95, 68.39 (C5H4), 69.90 (Cp), 36.38 (d, J P-C = 5.6 Hz, -CH2N-), 28.72 (d, J P-C = 37.7 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 24.32. MS (FAB+): [M]+ m/z 673 (48.18%), [M - Cl]+ m/z 638 (100%). Anal. Calcd for C25H24AuClFeNOP (673.7): C, 44.57; H, 3.59; N, 2.08. Found C, 44.73; H, 3.54; N, 2.19.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 42, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of [Ag\u00ad(OTf)\u00ad(<bold>L1</bold>)<sub>2</sub>] (<bold>2</bold>)</title><p>\n<italic toggle=\"yes\">Caution!</italic> Reactions\nwith silver salts should be protected from the light. To a solution\nof <bold>L1</bold> (0.1058 g, 0.24 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added [AgOTf] (0.0308 g, 0.12 mmol), and the mixture\nwas stirred for 1 h. Afterward the solution was evaporated to ca.\n5 mL and hexane was added (15 mL) to obtain a yellow solid: 73% yield\n(0.0997 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.59\u20137.23\n(m, 22H, Ph, NH), 4.80 (m, 4H, \u03b2-C<sub>5</sub>H<sub>4</sub>),\n4.29 (m, 4H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.18 (s, 10H, Cp),\n3.54 (m, br, 4H, \u2212CH<sub>2</sub>N\u2212), 2.72 (m, br, 4H,\n\u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR\n(CDCl<sub>3</sub>) \u03b4 (ppm): 132.88 (<italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.12 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.47 (<italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>),\n70.96, 68.67 (C<sub>5</sub>H<sub>4</sub>), 69.87 (Cp), 36.43 (\u2212CH<sub>2</sub>N\u2212), 27.29 (\u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, \u221260 \u00b0C)\n\u03b4 (ppm): 2.42 (2d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013Ag</sub> =\n577.0, 501.1 Hz). <sup>19</sup>F\u00ad{<sup>1</sup>H}-NMR (CDCl<sub>3</sub>) \u03b4 (ppm): \u221277.74. MS (FAB<sup>+</sup>): [M]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 989 (35%). Anal. Calcd for\nC<sub>55</sub>H<sub>48</sub>AgF<sub>3</sub>Fe<sub>2</sub>N<sub>2</sub>O<sub>5</sub>P<sub>2</sub>S (1139.5): C, 53.76, H, 4.25, N, 2.46;\nS, 2.81. Found: C, 53.46, H, 4.28, N, 2.42; S, 3.09.</p>", "clean_text": "Synthesis of [Ag(OTf)(L1)2] (2)\n\n Caution! Reactions with silver salts should be protected from the light. To a solution of L1 (0.1058 g, 0.24 mmol) in CH2Cl2 (20 mL) was added [AgOTf] (0.0308 g, 0.12 mmol), and the mixture was stirred for 1 h. Afterward the solution was evaporated to ca. 5 mL and hexane was added (15 mL) to obtain a yellow solid: 73% yield (0.0997 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.59-7.23 (m, 22H, Ph, NH), 4.80 (m, 4H, \u03b2-C5H4), 4.29 (m, 4H, \u03b1-C5H4), 4.18 (s, 10H, Cp), 3.54 (m, br, 4H, -CH2N-), 2.72 (m, br, 4H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 132.88 (o-C6H5), 131.12 (p-C6H5), 129.47 (m-C6H5), 70.96, 68.67 (C5H4), 69.87 (Cp), 36.43 (-CH2N-), 27.29 (-CH2P-). 31P{1H} NMR (CDCl3, -60 \u00b0C) \u03b4 (ppm): 2.42 (2d, J P-Ag = 577.0, 501.1 Hz). 19F{1H}-NMR (CDCl3) \u03b4 (ppm): -77.74. MS (FAB+): [M]+ m/z 989 (35%). Anal. Calcd for C55H48AgF3Fe2N2O5P2S (1139.5): C, 53.76, H, 4.25, N, 2.46; S, 2.81. Found: C, 53.46, H, 4.28, N, 2.42; S, 3.09.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 43, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis\nof [Ag\u00ad(OTf)\u00ad(<bold>L1</bold>)\u00ad(PPh<sub>3</sub>)] (<bold>3</bold>)</title><p>\n<italic toggle=\"yes\">Caution!</italic> Reactions with silver salts should be\nprotected from the light. To a solution of <bold>L1</bold> (0.044\ng, 0.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added [Ag\u00ad(OTf)\u00ad(PPh<sub>3</sub>)] (0.0518 g, 0.1 mmol), and the mixture was stirred for 1\nh. Afterward the solution was evaporated to ca. 5 mL and hexane (15\nmL) was added to obtain a yellow solid: 87% yield (0.0835 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.73\u20137.29 (m,\n26H, Ph, NH), 4.75 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.15\n(m, 7H, \u03b1-C<sub>5</sub>H<sub>4</sub>, Cp), 3.66 (m, 2H, \u2212CH<sub>2</sub>N\u2212), 2.83 (m, 2H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.85\n(C\ue5fbO), 134.08 (<italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 133.13 (<italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.24\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 131.13 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.50 (<italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 129.38 (<italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 75.45 (C<sub>\n<italic toggle=\"yes\">ipso</italic>\n</sub>), 70.63, 68.59 (C<sub>5</sub>H<sub>4</sub>), 69.89 (Cp), 36.19 (\u2212CH<sub>2</sub>N\u2212),\n27.78 (\u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 12.89 (2d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013Ag</sub> = 571.03, 495.04 Hz), 11.32 (m), 2.46 (2d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013Ag</sub> = 577.11, 500.17 Hz), 1.25 (2d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013Ag</sub> = 572.59, 495.6 Hz). <sup>19</sup>F\u00ad NMR (CDCl<sub>3</sub>) \u03b4 (ppm): \u221277.68.\nMS (FAB<sup>+</sup>): [M]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 810 (30.4%), [M \u2013 PPh<sub>3</sub>]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 548 (100%). Anal. Calcd for C<sub>44</sub>H<sub>39</sub>AgF<sub>3</sub>FeNO<sub>4</sub>P<sub>2</sub>S (960.5): C,\n55.02; H, 4.09; N, 1.46; S, 3.34. Found C, 55.16; H, 4.09; N, 1.46;\nS, 3.44.</p>", "clean_text": "Synthesis of [Ag(OTf)(L1)(PPh3)] (3)\n\n Caution! Reactions with silver salts should be protected from the light. To a solution of L1 (0.044 g, 0.1 mmol) in CH2Cl2 (20 mL) was added [Ag(OTf)(PPh3)] (0.0518 g, 0.1 mmol), and the mixture was stirred for 1 h. Afterward the solution was evaporated to ca. 5 mL and hexane (15 mL) was added to obtain a yellow solid: 87% yield (0.0835 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.73-7.29 (m, 26H, Ph, NH), 4.75 (m, 2H, \u03b2-C5H4), 4.15 (m, 7H, \u03b1-C5H4, Cp), 3.66 (m, 2H, -CH2N-), 2.83 (m, 2H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.85 (C\ue5fbO), 134.08 (o-C6H5), 133.13 (o-C6H5), 131.24 (p-C6H5), 131.13 (p-C6H5), 129.50 (m-C6H5), 129.38 (m-C6H5), 75.45 (C ipso ), 70.63, 68.59 (C5H4), 69.89 (Cp), 36.19 (-CH2N-), 27.78 (-CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 12.89 (2d, J P-Ag = 571.03, 495.04 Hz), 11.32 (m), 2.46 (2d, J P-Ag = 577.11, 500.17 Hz), 1.25 (2d, J P-Ag = 572.59, 495.6 Hz). 19F NMR (CDCl3) \u03b4 (ppm): -77.68. MS (FAB+): [M]+ m/z 810 (30.4%), [M - PPh3]+ m/z 548 (100%). Anal. Calcd for C44H39AgF3FeNO4P2S (960.5): C, 55.02; H, 4.09; N, 1.46; S, 3.34. Found C, 55.16; H, 4.09; N, 1.46; S, 3.44.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 44, "type": "text", "classification": ["synthesis condition"], "content": "<title>General Procedure for the Synthesis of Phosphinegold\u00ad(I) Thiolates\nand Thionucleobase Analogues</title><p>A suspension of thiol or thionucleobase (0.2 mmol) and K<sub>2</sub>CO<sub>3</sub> (1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was stirred for 30 min. Then, complex <bold>1</bold> (0.2 mmol) was added and this mixture was stirred overnight.\nThe solution was filtered, the solvent was evaporated to ca. 5 mL,\nand hexane was added (15 mL) to obtain a solid.</p>", "clean_text": "General Procedure for the Synthesis of Phosphinegold(I) Thiolates and Thionucleobase Analogues\n\nA suspension of thiol or thionucleobase (0.2 mmol) and K2CO3 (1 mmol) in CH2Cl2 (15 mL) was stirred for 30 min. Then, complex 1 (0.2 mmol) was added and this mixture was stirred overnight. The solution was filtered, the solvent was evaporated to ca. 5 mL, and hexane was added (15 mL) to obtain a solid.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 45, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of [Au\u00ad(2-thionicotinicacid)\u00ad(<bold>L1</bold>)] (<bold>4</bold>):</title><p>yellow solid, 65% yield (0.103\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 8.51 (d, <italic toggle=\"yes\">J</italic> = 7.2 Hz, 1H, H6), 8.40 (d, <italic toggle=\"yes\">J</italic> = 4.8 Hz,\n1H, H4), 7.73 (m, 4H, Ph), 7.49 (m, 6H, Ph), 7.13 (dd, <italic toggle=\"yes\">J</italic> = 7.8, 4.9 Hz, 1H, H5), 6.65 (m, br, 1H, NH), 4.69 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.34 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.21 (s, 5H, Cp), 3.71 (m, 2H, \u2212CH<sub>2</sub>N\u2212),\n3.10 \u2013 2.68 (m, 2H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.35\n(C\ue5fbO), 133.33 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.0 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 132.27\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.60 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 129.00 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 59.9 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 75.23 (C<sub>ipso</sub>), 70.81, 68.39 (C<sub>5</sub>H<sub>4</sub>), 69.91 (Cp), 36.46 (\u2212CH<sub>2</sub>N\u2212),\n28.78 (d, <italic toggle=\"yes\">J</italic> = 35.6 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 25.47.\nAnal. Calcd for C<sub>31</sub>H<sub>28</sub>AuFeN<sub>2</sub>O<sub>3</sub>PS (792.4): C, 46.99; H, 3.56; N, 3.54, S 4.05. Found: C,\n46.64; H, 3.49; N, 3.41; S,  3.79.</p>", "clean_text": "Synthesis of [Au(2-thionicotinicacid)(L1)] (4):\n\nyellow solid, 65% yield (0.103 g). 1H NMR (CDCl3) \u03b4 (ppm): 8.51 (d, J = 7.2 Hz, 1H, H6), 8.40 (d, J = 4.8 Hz, 1H, H4), 7.73 (m, 4H, Ph), 7.49 (m, 6H, Ph), 7.13 (dd, J = 7.8, 4.9 Hz, 1H, H5), 6.65 (m, br, 1H, NH), 4.69 (m, 2H, \u03b2-C5H4), 4.34 (m, 2H, \u03b1-C5H4), 4.21 (s, 5H, Cp), 3.71 (m, 2H, -CH2N-), 3.10 - 2.68 (m, 2H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.35 (C\ue5fbO), 133.33 (d, 2 J P-C = 13.0 Hz, o-C6H5), 132.27 (p-C6H5), 129.60 (d, 3 J P-C = 11.4 Hz, m-C6H5), 129.00 (d, 1 J P-C = 59.9 Hz, ipso-C6H5), 75.23 (Cipso), 70.81, 68.39 (C5H4), 69.91 (Cp), 36.46 (-CH2N-), 28.78 (d, J = 35.6 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 25.47. Anal. Calcd for C31H28AuFeN2O3PS (792.4): C, 46.99; H, 3.56; N, 3.54, S 4.05. Found: C, 46.64; H, 3.49; N, 3.41; S,  3.79.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 46, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of [Au\u00ad(2-thiocytosine)\u00ad(<bold>L1</bold>)] (<bold>5</bold>):</title><p>yellow solid, 73% yield (0.111\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.93 (s, 1H,\nNH), 7.84 (d, <italic toggle=\"yes\">J</italic> = 5.7 Hz, 1H, H6), 7.73 (m, 4H, Ph),\n7.45 (m, 6H, Ph), 6.07 (d, <italic toggle=\"yes\">J</italic> = 5.8 Hz, 1H, H5), 4.97\n(m, br, 2H, NH<sub>2</sub>), 4.71 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.26 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.13\n(s, 5H, Cp), 3.71 (m, 2H, \u2212CH<sub>2</sub>N\u2212), 2.92 (m,\n2H, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H}\nNMR (CDCl<sub>3</sub>) \u03b4 (ppm): 28.81. Anal. Calcd for C<sub>29</sub>H<sub>28</sub>AuFeN<sub>4</sub>OPS (764.4): C, 45.57; H,\n3.69; N, 7.33; S, 4.19. Found: C, 45.75; H, 3.83; N, 6.97; S, 3.89.</p>", "clean_text": "Synthesis of [Au(2-thiocytosine)(L1)] (5):\n\nyellow solid, 73% yield (0.111 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.93 (s, 1H, NH), 7.84 (d, J = 5.7 Hz, 1H, H6), 7.73 (m, 4H, Ph), 7.45 (m, 6H, Ph), 6.07 (d, J = 5.8 Hz, 1H, H5), 4.97 (m, br, 2H, NH2), 4.71 (m, 2H, \u03b2-C5H4), 4.26 (m, 2H, \u03b1-C5H4), 4.13 (s, 5H, Cp), 3.71 (m, 2H, -CH2N-), 2.92 (m, 2H, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 28.81. Anal. Calcd for C29H28AuFeN4OPS (764.4): C, 45.57; H, 3.69; N, 7.33; S, 4.19. Found: C, 45.75; H, 3.83; N, 6.97; S, 3.89.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 47, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of [Au\u00ad(2-thiouracil)\u00ad(<bold>L1</bold>)] (<bold>6</bold>):</title><p>yellow solid, 67% yield (0.102 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 10.42 (s, 1H, NH), 7.71 (m, 4H, Ph), 7.63\n(d, <italic toggle=\"yes\">J</italic> = 6.7 Hz, 1H, H6), 7.48 (m, 6H, Ph), 6.14 (d, <italic toggle=\"yes\">J</italic> = 6.6 Hz, 1H, H5), 4.69 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.29 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.14\n(s, 5H, Cp), 3.69 (m, 2H, \u2212CH<sub>2</sub>N\u2212), 2.93 (m,\n2H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H}\nNMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.52 (C\ue5fbO), 133.36\n(d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.2 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 132.13 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.63 (d, <sup>4</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 57.8 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 129.58 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 110.13\n(C5), 75.55 (C<sub>ipso</sub>), 70.74, 68.46 (C<sub>5</sub>H<sub>4</sub>), 69.84 (Cp), 36.51 (\u2212CH<sub>2</sub>N\u2212), 29.06 (d, <italic toggle=\"yes\">J</italic> = 36.8 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 28.82. Anal.\nCalcd for C<sub>29</sub>H<sub>27</sub>AuFeN<sub>3</sub>O<sub>2</sub>PS (765.4): C, 45.51; H, 3.56; N, 5.49; S, 4.19. Found: C, 45.47;\nH, 3.68; N, 5.20; S, 3.98.</p>", "clean_text": "Synthesis of [Au(2-thiouracil)(L1)] (6):\n\nyellow solid, 67% yield (0.102 g). 1H NMR (CDCl3) \u03b4 (ppm): 10.42 (s, 1H, NH), 7.71 (m, 4H, Ph), 7.63 (d, J = 6.7 Hz, 1H, H6), 7.48 (m, 6H, Ph), 6.14 (d, J = 6.6 Hz, 1H, H5), 4.69 (m, 2H, \u03b2-C5H4), 4.29 (m, 2H, \u03b1-C5H4), 4.14 (s, 5H, Cp), 3.69 (m, 2H, -CH2N-), 2.93 (m, 2H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.52 (C\ue5fbO), 133.36 (d, 2 J P-C = 13.2 Hz, o-C6H5), 132.13 (p-C6H5), 129.63 (d, 4 J P-C = 57.8 Hz, ipso-C6H5), 129.58 (d, 3 J P-C = 11.4 Hz, m-C6H5), 110.13 (C5), 75.55 (Cipso), 70.74, 68.46 (C5H4), 69.84 (Cp), 36.51 (-CH2N-), 29.06 (d, J = 36.8 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 28.82. Anal. Calcd for C29H27AuFeN3O2PS (765.4): C, 45.51; H, 3.56; N, 5.49; S, 4.19. Found: C, 45.47; H, 3.68; N, 5.20; S, 3.98.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 48, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of [Au\u00ad(6-thiopurine)\u00ad(<bold>L1</bold>)] (<bold>7</bold>):</title><p>yellow solid. 58% yield (0.092 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 8.64 (s, 1H, H9),\n8.13 (m, br, 1H, NH), 8.03 (s, 1H, H5), 7.70 (m, 4H, Ph), 7.42 (m,\n6H, Ph), 4.69 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.16 (s,\n2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.11 (s, 5H, Cp), 3.71 (m,\n2H, \u2212CH<sub>2</sub>N\u2212), 2.87 (m, 2H, CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.55\n(C\ue5fbO), 133.43 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.1 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.97\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.50 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 75.64 (C<sub>ipso</sub>), 70.64, 68.54\n(C<sub>5</sub>H<sub>4</sub>), 69.86 (Cp). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 25.64. Anal. Calcd for C<sub>30</sub>H<sub>27</sub>AuFeN<sub>5</sub>OPS (789.4): C, 45.64; H,\n3.45; N, 8.87; S, 4.06; found. C 45.50; H, 3.40; N, 8.67; S, 3.85.</p>", "clean_text": "Synthesis of [Au(6-thiopurine)(L1)] (7):\n\nyellow solid. 58% yield (0.092 g). 1H NMR (CDCl3) \u03b4 (ppm): 8.64 (s, 1H, H9), 8.13 (m, br, 1H, NH), 8.03 (s, 1H, H5), 7.70 (m, 4H, Ph), 7.42 (m, 6H, Ph), 4.69 (m, 2H, \u03b2-C5H4), 4.16 (s, 2H, \u03b1-C5H4), 4.11 (s, 5H, Cp), 3.71 (m, 2H, -CH2N-), 2.87 (m, 2H, CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.55 (C\ue5fbO), 133.43 (d, 2 J P-C = 13.1 Hz, o-C6H5), 131.97 (p-C6H5), 129.50 (d, 3 J P-C = 11.4 Hz, m-C6H5), 75.64 (Cipso), 70.64, 68.54 (C5H4), 69.86 (Cp). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 25.64. Anal. Calcd for C30H27AuFeN5OPS (789.4): C, 45.64; H, 3.45; N, 8.87; S, 4.06; found. C 45.50; H, 3.40; N, 8.67; S, 3.85.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 49, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of [Au<sub>2</sub>Cl<sub>2</sub>(<bold>L2</bold>)] (<bold>8</bold>)</title><p>To a solution of <bold>L2</bold> (0.1771 g, 0.15\nmmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added [AuCl\u00ad(tht)]\n(0.1282 g, 0.30 mmol), and the mixture was stirred for 1 h. Afterward,\nthe solution was evaporated to ca. 5 mL and hexane was added (15 mL)\nto obtain a yellow solid: 93% yield (0.094 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.73 (m, 8H, Ph), 7.54 (m, br, 12H, Ph),\n4.59 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.40 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.24 (s, 5H, Cp), 3.73 (m, br, 4H, \u2212CH<sub>2</sub>N\u2212), 2.80 (m, br, 4H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 133.37\n(d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.6 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 132.65 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.89 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 10.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 70.92, 70.47 (C<sub>5</sub>H<sub>4</sub>), 70.17\n(Cp). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4\n(ppm): 25.67, 22.24. MS (FAB<sup>+</sup>): [M]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 1117 (45%). Anal. Calcd for C<sub>39</sub>H<sub>37</sub>Au<sub>2</sub>Cl<sub>2</sub>FeNOP<sub>2</sub> (673.7):\nC, 41.88; H, 3.33; N, 1.25. Found: C, 41.76; H, 3.47; N, 1.26.</p>", "clean_text": "Synthesis of [Au2Cl2(L2)] (8)\n\nTo a solution of L2 (0.1771 g, 0.15 mmol) in CH2Cl2 (20 mL) was added [AuCl(tht)] (0.1282 g, 0.30 mmol), and the mixture was stirred for 1 h. Afterward, the solution was evaporated to ca. 5 mL and hexane was added (15 mL) to obtain a yellow solid: 93% yield (0.094 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.73 (m, 8H, Ph), 7.54 (m, br, 12H, Ph), 4.59 (m, 2H, \u03b2-C5H4), 4.40 (m, 2H, \u03b1-C5H4), 4.24 (s, 5H, Cp), 3.73 (m, br, 4H, -CH2N-), 2.80 (m, br, 4H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 133.37 (d, 2 J P-C = 13.6 Hz, o-C6H5), 132.65 (p-C6H5), 129.89 (d, 3 J P-C = 10.4 Hz, m-C6H5), 70.92, 70.47 (C5H4), 70.17 (Cp). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 25.67, 22.24. MS (FAB+): [M]+ m/z 1117 (45%). Anal. Calcd for C39H37Au2Cl2FeNOP2 (673.7): C, 41.88; H, 3.33; N, 1.25. Found: C, 41.76; H, 3.47; N, 1.26.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 50, "type": "text", "classification": ["synthesis condition"], "content": "<title>[Au<sub>2</sub>(2-thiocytosine)<sub>2</sub>(<bold>L2</bold>)] (<bold>9</bold>):</title><p>yellow solid, 70% yield (0.182 g). <sup>1</sup>H NMR\n(CDCl<sub>3</sub>) \u03b4 (ppm): 7.85 (d, <italic toggle=\"yes\">J</italic> = 5.7\nHz, 2H, H6), 7.74 (m, 8H, Ph), 7.47 (m, 12H, Ph), 5.83 (d, <italic toggle=\"yes\">J</italic> = 5.5 Hz, 2H, H5), 5.13 (m, br, 4H, NH<sub>2</sub>), 4.46\n(m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.21 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.19 (s, 5H, Cp), 3.90 (m, br, 4H, \u2212CH<sub>2</sub>N\u2212), 2.80 (m, br, 4H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.73\n(C\ue5fbO), 162.13 (C4), 155.69 (C6), 133.47 (d, <italic toggle=\"yes\">J</italic> = 13.7 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 132.04\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.58 (d, <italic toggle=\"yes\">J</italic> = 11.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 100.45 (C5), 70.46, 70.35 (C<sub>5</sub>H<sub>4</sub>), 70.13\n(Cp). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (acetone, \u221285 \u00b0C)\n\u03b4 (ppm): 29.36, 27.97. Anal. Calcd for C<sub>47</sub>H<sub>45</sub>Au<sub>2</sub>FeN<sub>7</sub>OP<sub>2</sub>S<sub>2</sub> (1299.8):\nC, 43.43; H, 3.49; N, 7.54; S, 4.93. Found: C, 43.17; H, 3.32; N,\n7.39; S, 4.67.</p>", "clean_text": "[Au2(2-thiocytosine)2(L2)] (9):\n\nyellow solid, 70% yield (0.182 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.85 (d, J = 5.7 Hz, 2H, H6), 7.74 (m, 8H, Ph), 7.47 (m, 12H, Ph), 5.83 (d, J = 5.5 Hz, 2H, H5), 5.13 (m, br, 4H, NH2), 4.46 (m, 2H, \u03b2-C5H4), 4.21 (m, 2H, \u03b1-C5H4), 4.19 (s, 5H, Cp), 3.90 (m, br, 4H, -CH2N-), 2.80 (m, br, 4H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.73 (C\ue5fbO), 162.13 (C4), 155.69 (C6), 133.47 (d, J = 13.7 Hz, o-C6H5), 132.04 (p-C6H5), 129.58 (d, J = 11.4 Hz, m-C6H5), 100.45 (C5), 70.46, 70.35 (C5H4), 70.13 (Cp). 31P{1H} NMR (acetone, -85 \u00b0C) \u03b4 (ppm): 29.36, 27.97. Anal. Calcd for C47H45Au2FeN7OP2S2 (1299.8): C, 43.43; H, 3.49; N, 7.54; S, 4.93. Found: C, 43.17; H, 3.32; N, 7.39; S, 4.67.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 51, "type": "text", "classification": ["synthesis condition"], "content": "<title>[Au<sub>2</sub>(TG)<sub>2</sub>(<bold>L2</bold>)] (<bold>10</bold>):</title><p>yellow solid, 75% yield (0.265 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.74 (m, 8H, Ph),\n7.49 (m, 12H, Ph), 5.13 (m, 8H, H1, H4, H5, H6), 4.49 (m, 1H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.36 (m, 1H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.27 (m, 1H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.24 (m, 1H,\n\u03b1-C<sub>5</sub>H<sub>4</sub>), 4.20 (dd, <italic toggle=\"yes\">J</italic> =\n12.3, 4.8 Hz, 1H, \u2212CH<sub>2</sub>\u2212), 4.16 (s, 5H, Cp),\n4.09 (dd, <italic toggle=\"yes\">J</italic> = 12.2, 2.4 Hz, 1H, \u2212CH<sub>2</sub>\u2212), 3.76 (m, br, 6H, H3, \u2212CH<sub>2</sub>N\u2212),\n2.75 (m, br, 4H, \u2212CH<sub>2</sub>P\u2212), 2.01 (s, 6H, \u2212CH<sub>3</sub>), 1.96 (s, 6H, \u2212CH<sub>3</sub>), 1.92 (s, 6H, \u2212CH<sub>3</sub>), 1.86 (s, 6H, \u2212CH<sub>3</sub>). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.20 (N\u2013C\ue5fbO),\n170.88, 170.40, 169.86, 169.75 (O\u2013C\ue5fbO), 133.43 (t, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 14.2 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.69 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.55 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 9.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 129.50 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 10.1 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 83.42\n(C1), 77.83 (C6), 75.86 (C3), 74.26 (C5), 70.47, 70.44 (C<sub>5</sub>H<sub>4</sub>), 70.00 (Cp), 69.09 (C4), 62.96 (\u2212CH<sub>2</sub>\u2212), 21.26, 20.88, 20.83, 20.79 (\u2212CH<sub>3</sub>). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, \u221260 \u00b0C)\n\u03b4 (ppm): 29.44, 27.11. Anal. Calcd for C<sub>67</sub>H<sub>75</sub>Au<sub>2</sub>FeNO<sub>19</sub>P<sub>2</sub>S<sub>2</sub> (1774.2):\nC, 45.36; H, 4.26; N, 0.79; S, 3.61. Found: C, 45.25; H, 4.21; N,\n0.96; S, 3.84.</p>", "clean_text": "[Au2(TG)2(L2)] (10):\n\nyellow solid, 75% yield (0.265 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.74 (m, 8H, Ph), 7.49 (m, 12H, Ph), 5.13 (m, 8H, H1, H4, H5, H6), 4.49 (m, 1H, \u03b2-C5H4), 4.36 (m, 1H, \u03b2-C5H4), 4.27 (m, 1H, \u03b1-C5H4), 4.24 (m, 1H, \u03b1-C5H4), 4.20 (dd, J = 12.3, 4.8 Hz, 1H, -CH2-), 4.16 (s, 5H, Cp), 4.09 (dd, J = 12.2, 2.4 Hz, 1H, -CH2-), 3.76 (m, br, 6H, H3, -CH2N-), 2.75 (m, br, 4H, -CH2P-), 2.01 (s, 6H, -CH3), 1.96 (s, 6H, -CH3), 1.92 (s, 6H, -CH3), 1.86 (s, 6H, -CH3). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.20 (N-C\ue5fbO), 170.88, 170.40, 169.86, 169.75 (O-C\ue5fbO), 133.43 (t, 2 J P-C = 14.2 Hz, o-C6H5), 131.69 (p-C6H5), 129.55 (d, 3 J P-C = 9.4 Hz, m-C6H5), 129.50 (d, 3 J P-C = 10.1 Hz, m-C6H5), 83.42 (C1), 77.83 (C6), 75.86 (C3), 74.26 (C5), 70.47, 70.44 (C5H4), 70.00 (Cp), 69.09 (C4), 62.96 (-CH2-), 21.26, 20.88, 20.83, 20.79 (-CH3). 31P{1H} NMR (CDCl3, -60 \u00b0C) \u03b4 (ppm): 29.44, 27.11. Anal. Calcd for C67H75Au2FeNO19P2S2 (1774.2): C, 45.36; H, 4.26; N, 0.79; S, 3.61. Found: C, 45.25; H, 4.21; N, 0.96; S, 3.84.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 52, "type": "text", "classification": ["property", "synthesis condition"], "content": "<title>[Au<sub>2</sub>(TG)<sub>2</sub>(\u03bc-<bold>L3</bold>)] (<bold>11</bold>):</title><p>yellow solid, 70% yield (0.253\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.76 (m, 8H,\nPh), 7.46 (m, 12H, Ph), 5.19 (m, 8H, H5, H6, H4, H1), 4.53 (m, 2H,\nCp), 4.45 (m, 2H, Cp), 4.32 (m, 2H, Cp), 4.26 (m, 2H, Cp), 4.23 (m,\n2H, \u2212CH<sub>2</sub>\u2212), 4.12 (m, 2H, \u2212CH<sub>2</sub>\u2212), 3.72 (m, 6H, H3, \u2212CH<sub>2</sub>N\u2212), 2.91\n(m, 4H, \u2212CH<sub>2</sub>P\u2212), 2.08 (s, 6H, COCH<sub>3</sub>), 2.03 (s, 6H, COCH<sub>3</sub>), 1.98 (s, 6H, COCH<sub>3</sub>),\n1.88 (s, 6H, COCH<sub>3</sub>). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR\n(CDCl<sub>3</sub>) \u03b4 (ppm): 170.95, 170.89, 170.48, 170.38,\n169.83 (C\ue5fbO), 133.44 (t, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.3 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.72 (d, <sup>4</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 3.1 Hz, <italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.48\n(d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 10.9 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 129.42 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.0 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 83.51 (C1), 78.12 (C6), 75.90 (C3), 74.31\n(C5), 71.59, 71.44, 69.94 (C<sub>5</sub>H<sub>4</sub>), 69.02 (C4),\n62.86 (\u2212CH<sub>2</sub>\u2212), 36.68 (\u2212CH<sub>2</sub>N\u2212), 28.39 (d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 31.2\nHz, \u2212CH<sub>2</sub>P\u2212), 21.46, 20.89, 20.83 (\u2212CH<sub>3</sub>\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 25.54. Anal. Calcd for C<sub>68</sub>H<sub>76</sub>Au<sub>2</sub>FeN<sub>2</sub>O<sub>20</sub>P<sub>2</sub>S<sub>2</sub> (1817.2): C 44.94; H, 4.22; N, 1.54; S, 3.53. Found: C, 44.93; H,\n3.90; N, 1.46; S, 3.59.</p>", "clean_text": "[Au2(TG)2(\u03bc-L3)] (11):\n\nyellow solid, 70% yield (0.253 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.76 (m, 8H, Ph), 7.46 (m, 12H, Ph), 5.19 (m, 8H, H5, H6, H4, H1), 4.53 (m, 2H, Cp), 4.45 (m, 2H, Cp), 4.32 (m, 2H, Cp), 4.26 (m, 2H, Cp), 4.23 (m, 2H, -CH2-), 4.12 (m, 2H, -CH2-), 3.72 (m, 6H, H3, -CH2N-), 2.91 (m, 4H, -CH2P-), 2.08 (s, 6H, COCH3), 2.03 (s, 6H, COCH3), 1.98 (s, 6H, COCH3), 1.88 (s, 6H, COCH3). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 170.95, 170.89, 170.48, 170.38, 169.83 (C\ue5fbO), 133.44 (t, 2 J P-C = 13.3 Hz, o-C6H5), 131.72 (d, 4 J P-C = 3.1 Hz, p-C6H5), 129.48 (d, 3 J P-C = 10.9 Hz, m-C6H5), 129.42 (d, 3 J P-C = 11.0 Hz, m-C6H5), 83.51 (C1), 78.12 (C6), 75.90 (C3), 74.31 (C5), 71.59, 71.44, 69.94 (C5H4), 69.02 (C4), 62.86 (-CH2-), 36.68 (-CH2N-), 28.39 (d, J P-C = 31.2 Hz, -CH2P-), 21.46, 20.89, 20.83 (-CH3-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 25.54. Anal. Calcd for C68H76Au2FeN2O20P2S2 (1817.2): C 44.94; H, 4.22; N, 1.54; S, 3.53. Found: C, 44.93; H, 3.90; N, 1.46; S, 3.59.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property', 'synthesis condition']"}}, {"idx": 53, "type": "text", "classification": ["property", "synthesis condition"], "content": "<title>[Au<sub>2</sub>(2-thiocytosine)<sub>2</sub>(\u03bc-<bold>L3</bold>)] (<bold>12</bold>):</title><p>yellow solid,\n74% yield (0.198 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4\n(ppm): 8.30 (m, br, 2H, NH), 7.84 (d, <italic toggle=\"yes\">J</italic> = 5.8 Hz,\n2H, H6), 7.74 (m, 8H, Ph), 7.44 (m, 12H, Ph), 6.06 (d, <italic toggle=\"yes\">J</italic> = 5.8 Hz, 2H, H5), 4.71 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.19 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 3.71 (m, 4H,\n\u2212CH<sub>2</sub>N\u2212), 2.90 (m, 4H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H}-NMR (CDCl<sub>3</sub>)\n\u03b4 (ppm): 178.77 (C2), 170.92 (C\ue5fbO), 162.61 (C4), 155.28\n(C6), 133.49 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.2 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.84\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.46 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 8.1 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 100.65 (C5), 72.25, 70.24 (C<sub>5</sub>H<sub>4</sub>), 36.53 (\u2212CH<sub>2</sub>N\u2212), 28.80 (d, <italic toggle=\"yes\">J</italic> = 29.8 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 28.20. Anal.\nCalcd for C<sub>48</sub>H<sub>46</sub>Au<sub>2</sub>FeN<sub>8</sub>O<sub>2</sub>P<sub>2</sub>S<sub>2</sub> (1342.8): C, 42.93; H, 3.45;\nN, 8.34; S, 4.78. Found: C, 43.07; H, 3.68; N, 8.22; S, 4.61.</p>", "clean_text": "[Au2(2-thiocytosine)2(\u03bc-L3)] (12):\n\nyellow solid, 74% yield (0.198 g). 1H NMR (CDCl3) \u03b4 (ppm): 8.30 (m, br, 2H, NH), 7.84 (d, J = 5.8 Hz, 2H, H6), 7.74 (m, 8H, Ph), 7.44 (m, 12H, Ph), 6.06 (d, J = 5.8 Hz, 2H, H5), 4.71 (m, 2H, \u03b2-C5H4), 4.19 (m, 2H, \u03b1-C5H4), 3.71 (m, 4H, -CH2N-), 2.90 (m, 4H, -CH2P-). 13C{1H}-NMR (CDCl3) \u03b4 (ppm): 178.77 (C2), 170.92 (C\ue5fbO), 162.61 (C4), 155.28 (C6), 133.49 (d, 2 J P-C = 11.2 Hz, o-C6H5), 131.84 (p-C6H5), 129.46 (d, 3 J P-C = 8.1 Hz, m-C6H5), 100.65 (C5), 72.25, 70.24 (C5H4), 36.53 (-CH2N-), 28.80 (d, J = 29.8 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 28.20. Anal. Calcd for C48H46Au2FeN8O2P2S2 (1342.8): C, 42.93; H, 3.45; N, 8.34; S, 4.78. Found: C, 43.07; H, 3.68; N, 8.22; S, 4.61.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property', 'synthesis condition']"}}, {"idx": 54, "type": "text", "classification": "error", "content": "<title>[Au<sub>2</sub>(TG)<sub>2</sub>(\u03bc-dppf)] (<bold>13</bold>):</title><p>yellow solid, 83% yield (0.277 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.48 (m, 10H, Ph), 5.16 (m, 4H, H5, H4), 4.91 (m,\n2H, Cp), 4.85 (m, 2H, Cp), 4.33 (m, 2H, Cp), 4.27 (m, 3H, Cp, \u2212CH<sub>2</sub>\u2212), 4.11 (m, 1H, \u2212CH<sub>2</sub>\u2212), 3.79\n(m, 1H, H3), 2.09, 2.01, 1.97, 1.87 (s, 12H, COCH<sub>3</sub>). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 170.82,\n170.37, 169.92, 169.69 (C\ue5fbO), 133.89 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.9 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 133.73 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.8 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.66 (d, <sup>4</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 2.5 Hz, <italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 131.61\n(d, <sup>4</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 2.4 Hz, <italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 131.53 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 57.9 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 131.35 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 58.1 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 129.16 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.5 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 129.14\n(d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.5 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 83.62 (C1), 78.14 (C6), 76.03\n(C3), 75.27 (m, C<sub>5</sub>H<sub>4</sub>), 74.41 (C5), 71.96 (d, <italic toggle=\"yes\">J</italic> = 65.1 Hz, <italic toggle=\"yes\">ipso-</italic>C<sub>5</sub>H<sub>4</sub>), 69.18 (C4), 63.05 (\u2212CH<sub>2</sub>\u2212), 21.31, 20.93,\n20.86, 20.78 (CO\u2013CH<sub>3</sub>). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 33.46. Anal. Calcd for C<sub>62</sub>H<sub>66</sub>Au<sub>2</sub>FeO<sub>18</sub>P<sub>2</sub>S<sub>2</sub> (1675.03): C, 44.46; H, 3.97; S, 3.83. Found: C, 44.39;\nH, 3.75; S, 3.59.</p>", "clean_text": "[Au2(TG)2(\u03bc-dppf)] (13):\n\nyellow solid, 83% yield (0.277 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.48 (m, 10H, Ph), 5.16 (m, 4H, H5, H4), 4.91 (m, 2H, Cp), 4.85 (m, 2H, Cp), 4.33 (m, 2H, Cp), 4.27 (m, 3H, Cp, -CH2-), 4.11 (m, 1H, -CH2-), 3.79 (m, 1H, H3), 2.09, 2.01, 1.97, 1.87 (s, 12H, COCH3). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 170.82, 170.37, 169.92, 169.69 (C\ue5fbO), 133.89 (d, 2 J P-C = 13.9 Hz, o-C6H5), 133.73 (d, 2 J P-C = 13.8 Hz, o-C6H5), 131.66 (d, 4 J P-C = 2.5 Hz, p-C6H5), 131.61 (d, 4 J P-C = 2.4 Hz, p-C6H5), 131.53 (d, 1 J P-C = 57.9 Hz, ipso-C6H5), 131.35 (d, 1 J P-C = 58.1 Hz, ipso-C6H5), 129.16 (d, 3 J P-C = 11.5 Hz, m-C6H5), 129.14 (d, 3 J P-C = 11.5 Hz, m-C6H5), 83.62 (C1), 78.14 (C6), 76.03 (C3), 75.27 (m, C5H4), 74.41 (C5), 71.96 (d, J = 65.1 Hz, ipso-C5H4), 69.18 (C4), 63.05 (-CH2-), 21.31, 20.93, 20.86, 20.78 (CO-CH3). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 33.46. Anal. Calcd for C62H66Au2FeO18P2S2 (1675.03): C, 44.46; H, 3.97; S, 3.83. Found: C, 44.39; H, 3.75; S, 3.59.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 55, "type": "text", "classification": ["synthesis condition"], "content": "<title>[Au<sub>2</sub>(2-thiouracil)<sub>2</sub>(\u03bc-dppf)] (<bold>14</bold>):</title><p>yellow solid, 85% yield\n(0.204 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.77\n(d, <italic toggle=\"yes\">J</italic> = 6.3 Hz, 2H, H6), 7.66 (m, 8H, Ph), 7.47 (m,\n12H, Ph), 6.22 (d, <italic toggle=\"yes\">J</italic> = 6.3 Hz, 2H, H5), 4.63 (m,\nbr, 4H, Cp), 4.12 (m, br, 4H, Cp). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR\n(CDCl<sub>3</sub>) \u03b4 (ppm): 154.41 (C6), 133.91 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.9 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.82 (d, <sup>4</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 2.3 Hz, <italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 131.16 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 61.0 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 129.17\n(d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.7 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 110.42 (C5), 73.41 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 8.4 Hz, Cp), 71.44\n(d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 66.3 Hz, <italic toggle=\"yes\">ipso</italic>-Cp). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 27.34. Anal. Calcd for C<sub>42</sub>H<sub>34</sub>Au<sub>2</sub>FeN<sub>4</sub>O<sub>2</sub>P<sub>2</sub>S<sub>2</sub> (1202.6): C, 41.95; H, 2.85; N, 4.66; S, 5.33. Found: C, 41.90;\nH, 2.92; N, 4.63; S, 5.30.</p>", "clean_text": "[Au2(2-thiouracil)2(\u03bc-dppf)] (14):\n\nyellow solid, 85% yield (0.204 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.77 (d, J = 6.3 Hz, 2H, H6), 7.66 (m, 8H, Ph), 7.47 (m, 12H, Ph), 6.22 (d, J = 6.3 Hz, 2H, H5), 4.63 (m, br, 4H, Cp), 4.12 (m, br, 4H, Cp). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 154.41 (C6), 133.91 (d, 2 J P-C = 13.9 Hz, o-C6H5), 131.82 (d, 4 J P-C = 2.3 Hz, p-C6H5), 131.16 (d, 1 J P-C = 61.0 Hz, ipso-C6H5), 129.17 (d, 2 J P-C = 11.7 Hz, m-C6H5), 110.42 (C5), 73.41 (d, 3 J P-C = 8.4 Hz, Cp), 71.44 (d, 1 J P-C = 66.3 Hz, ipso-Cp). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 27.34. Anal. Calcd for C42H34Au2FeN4O2P2S2 (1202.6): C, 41.95; H, 2.85; N, 4.66; S, 5.33. Found: C, 41.90; H, 2.92; N, 4.63; S, 5.30.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 56, "type": "text", "classification": ["else"], "content": "<title>Cell Culture</title><p>Four\ndifferent cell lines were cultivated: HEP-G2 cells, NIH-3T3 cells,\nPC-12 cells, and A-549 cells. HEP-G2 cells are human hepatocellular\ncarcinoma cells (DMSZ no.: ACC 180). NIH-3T3 cells are mouse fibroblasts\n(DMSZ no.: ACC 59). PC-12 cells are rat adrenal pheochromocytoma cells\n(DSMZ no.: ACC 159). A-549 cells are human lung carcinoma cells (DSMZ\nno.: ACC 107).</p>", "clean_text": "Cell Culture\n\nFour different cell lines were cultivated: HEP-G2 cells, NIH-3T3 cells, PC-12 cells, and A-549 cells. HEP-G2 cells are human hepatocellular carcinoma cells (DMSZ no.: ACC 180). NIH-3T3 cells are mouse fibroblasts (DMSZ no.: ACC 59). PC-12 cells are rat adrenal pheochromocytoma cells (DSMZ no.: ACC 159). A-549 cells are human lung carcinoma cells (DSMZ no.: ACC 107).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 57, "type": "text", "classification": ["else"], "content": "<p>All cell lines were cultivated in Dulbecco\u2019s\nModified Eagle\u2019s medium (DMEM, D7777 Sigma-Aldrich, Steinheim,\nGermany) supplemented with the according serum (Table ) and 1% antibiotics (penicillin/100U/mL and streptomycin/100\n\u03bcg/mL) in a humidified environment at 37 \u00b0C/5% CO<sub>2</sub>. After 3\u20134 days the cells had grown to confluence and were\nthen detached with trypsin and cultured in a new cell culture flask.</p>", "clean_text": "All cell lines were cultivated in Dulbecco's Modified Eagle's medium (DMEM, D7777 Sigma-Aldrich, Steinheim, Germany) supplemented with the according serum (Table ) and 1% antibiotics (penicillin/100U/mL and streptomycin/100 \u03bcg/mL) in a humidified environment at 37 \u00b0C/5% CO2. After 3-4 days the cells had grown to confluence and were then detached with trypsin and cultured in a new cell culture flask.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 58, "type": "text", "classification": ["else"], "content": "<title>Cultivation with Suspensions</title><p>Wells of a 96-well plate were\nseeded with a defined number of cells (see Table ), depending on the doubling times, and incubated for 3 days.\nAt day 4 the medium of each well was removed and 200 \u03bcL of the\ndifferent gold and silver complexes in varying concentrations in the\ncell culture medium was added to the wells (1\u2013100 \u03bcM).\nThe cells were cultivated for 3 days more, and then the viability\nof the cells was determined by the MTT assay.</p>", "clean_text": "Cultivation with Suspensions\n\nWells of a 96-well plate were seeded with a defined number of cells (see Table ), depending on the doubling times, and incubated for 3 days. At day 4 the medium of each well was removed and 200 \u03bcL of the different gold and silver complexes in varying concentrations in the cell culture medium was added to the wells (1-100 \u03bcM). The cells were cultivated for 3 days more, and then the viability of the cells was determined by the MTT assay.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 59, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<title>DMEM Additives\nand the Cell Numbers Per Well Used for the Experiments</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"3\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">cell line</oasis:entry>\n<oasis:entry align=\"center\">DMEM additive</oasis:entry>\n<oasis:entry align=\"center\">cell number\nper well</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>A-549</oasis:entry>\n<oasis:entry>10% FCS (fetal calf serum)</oasis:entry>\n<oasis:entry>8000</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>NIH-3T3</oasis:entry>\n<oasis:entry>10% FCS</oasis:entry>\n<oasis:entry>6000</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>PC-12</oasis:entry>\n<oasis:entry>10% HOS, 5% NCS (newborn calf serum), 1%\nsodiumpyruvate, 1% <sc>l</sc>-glutamine</oasis:entry>\n<oasis:entry>10000</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>HEP-G2</oasis:entry>\n<oasis:entry>10% FCS</oasis:entry>\n<oasis:entry>10000</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 60, "type": "text", "classification": ["else"], "content": "<title>MTT</title><p>The cells\nwere cultivated in 96-well plates. The viability of the cells was\nanalyzed by the MTT ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium\nbromide) assay (Sigma-Aldrich, Steinheim, Germany). This assay is\nbased on the hydrolysis of the tetrazonium ring by mitochondrial dehydrogenase\nenzymes to an insoluble blue reaction product. To perform the MTT\nassay, at first medium had to be removed from each well. Afterward,\n100 \u03bcL of fresh medium and 10 \u03bcL of MTT solution (5 mg/mL\nPBS, sterile) were added to each well and incubated for 4 h at 37 \u00b0C/5%\nCO<sub>2</sub>. Subsequently, 100 \u03bcL of 10% SDS (sodium dodecyl\nsulfate) in 0.01 M HCl was added and the plates were further incubated\nfor 24 h. The transmission signals at 570/630 nm were determined using\na microplate reader (Bio-Rad, Mu\u0308nchen, Germany).</p>", "clean_text": "MTT\n\nThe cells were cultivated in 96-well plates. The viability of the cells was analyzed by the MTT ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay (Sigma-Aldrich, Steinheim, Germany). This assay is based on the hydrolysis of the tetrazonium ring by mitochondrial dehydrogenase enzymes to an insoluble blue reaction product. To perform the MTT assay, at first medium had to be removed from each well. Afterward, 100 \u03bcL of fresh medium and 10 \u03bcL of MTT solution (5 mg/mL PBS, sterile) were added to each well and incubated for 4 h at 37 \u00b0C/5% CO2. Subsequently, 100 \u03bcL of 10% SDS (sodium dodecyl sulfate) in 0.01 M HCl was added and the plates were further incubated for 24 h. The transmission signals at 570/630 nm were determined using a microplate reader (Bio-Rad, Mu\u0308nchen, Germany).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 61, "type": "text", "classification": ["else"], "content": "<title>Crystallography</title><p>Crystals were mounted in inert oil on glass fibers and transferred\nto the cold gas stream of a SMART APEX CCD diffractometer equipped\nwith a low-temperature attachment. Data were collected using monochromated\nMo K\u03b1 radiation (\u03bb = 0.71073 \u00c5) (scan type \u03c9).\nAbsorption corrections based on multiple scans were applied with the\nprogram SADABS. The structures were solved\nby direct methods and refined on <italic toggle=\"yes\">F</italic>\n<sup>2</sup> using\nthe program SHELXL-97. All non-hydrogen\natoms were refined anisotropically. In all cases, hydrogen atoms were\nincluded in calculated positions and refined using a riding model.\nRefinements were carried out by full-matrix least squares on <italic toggle=\"yes\">F</italic>\n<sup>2</sup> for all data.</p>", "clean_text": "Crystallography\n\nCrystals were mounted in inert oil on glass fibers and transferred to the cold gas stream of a SMART APEX CCD diffractometer equipped with a low-temperature attachment. Data were collected using monochromated Mo K\u03b1 radiation (\u03bb = 0.71073 \u00c5) (scan type \u03c9). Absorption corrections based on multiple scans were applied with the program SADABS. The structures were solved by direct methods and refined on F 2 using the program SHELXL-97. All non-hydrogen atoms were refined anisotropically. In all cases, hydrogen atoms were included in calculated positions and refined using a riding model. Refinements were carried out by full-matrix least squares on F 2 for all data.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 62, "type": "text", "classification": ["else"], "content": "<p>CIF files giving X-ray crystallographic\ndata for compounds <bold>8</bold> and <bold>13</bold>. This material\nis available free of charge via the Internet at <uri xlink:href=\"http://pubs.acs.org\">http://pubs.acs.org</uri>.</p><p>The authors declare\nno competing financial interest.</p><title>References</title>", "clean_text": "CIF files giving X-ray crystallographic data for compounds 8 and 13. This material is available free of charge via the Internet at http://pubs.acs.org.\n\nThe authors declare no competing financial interest.\n\nReferences", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": "39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 55", "type": "text", "classification": "synthesis condition", "content": "<title>Synthesis of PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc (<bold>L1</bold>)</title><p>To a solution of 2-(diphenylphosphino)\u00adethylamine\n(46 \u03bcL, 0.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was\nadded triethylamine (60 \u03bcL, 0.43 mmol); the solution was stirred\nfor 10 min at room temperature, and then it was poured into an ice\nbath, a solution of chlorocarbonylferrocene in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added dropwise, and the mixture was stirred overnight.\nAn aqueous solution of NaHCO<sub>3</sub> (30 mL) was added, the two\nphases were separated, and anhydrous Na<sub>2</sub>SO<sub>4</sub> was\nadded to the organic phase for drying. The solvent was evaporated\nto ca. 5 mL, and hexane (20 mL) was added to obtain a yellow solid:\n75% yield (0.066 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4\n(ppm): 7.47 (m, 4H, Ph), 7.36 (m, 6H, Ph), 5.92 (m, br, 1H, NH), 4.58\n(m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.31 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.19 (s, 5H, Cp), 3.54 (m, 2H, \u2212CH<sub>2</sub>N\u2212), 2.40 (t, <italic toggle=\"yes\">J</italic> = 7.1 Hz, 2H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 170.34 (C\ue5fbO), 137.70 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.4 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 132.91 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 18.7 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 129.07 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>),\n128.82 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 6.9\nHz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 76.15 (C<sub>ipso</sub>), 70.48, 68.18 (C<sub>5</sub>H<sub>4</sub>), 69.89 (Cp), 36.99 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sup>\n<italic toggle=\"yes\"></italic>\n</sup>\n<sub>C\u2013P</sub> = 18.8 Hz, \u2212CH<sub>2</sub>N\u2212), 28.93 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sup>\n<italic toggle=\"yes\"></italic>\n</sup>\n<sub>C\u2013P</sub> = 12.6 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): \u221220.93. MS\n(FAB<sup>+</sup>): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 442 (100%).\nAnal. Calcd for C<sub>25</sub>H<sub>24</sub>FeNOP (441.3): C, 68.04;\nH, 5.48; N, 3.17. Found: C, 67.82; H, 5.45; N, 3.29.</p><title>Synthesis\nof (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCOFc\n(<bold>L2</bold>)</title><p>To a solution of bis\u00ad[2-(diphenylphosphino)\u00adethyl]\u00adamine\n(0.4777 g, 1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added\ntriethylamine (300 \u03bcL, 2.1 mmol); the solution was stirred for\n10 min at room temperature and then poured into an ice bath, a solution\nof chlorocarbonylferrocene in CH<sub>2</sub>Cl<sub>2</sub> (20 mL)\nwas added dropwise, and the mixture was then stirred overnight. An\naqueous solution of NaHCO<sub>3</sub> (30 mL) was added, the two phases\nwere separated, and anhydrous Na<sub>2</sub>SO<sub>4</sub> was added\nto the organic phase. The solvent was evaporated to ca. 15 mL, and\nhexane (40 mL) was added to obtain a white solid: 85% yield (0.555\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.38 (m, 20H),\n4.37 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.18 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.13 (s, 5H, Cp), 3.51 (m, 4H, \u2212CH<sub>2</sub>N\u2212), 2.33 (m, 4H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 170.33\n(C\ue5fbO), 132.88 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 18.8 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 128.77\n(d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 6.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 70.43, 69.77 (C<sub>5</sub>H<sub>4</sub>), 69.84 (Cp). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): \u221220.11, \u221221.54. MS (FAB<sup>+</sup>): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 654 (50%). Anal.\nCalcd for C<sub>39</sub>H<sub>37</sub>FeNOP<sub>2</sub> (653.5): C,\n71.68; H, 5.71; N, 2.14. Found: C, 71.76; H, 5.27; N, 1.96.</p><title>Synthesis\nof [AuCl\u00ad(<bold>L1</bold>)] (<bold>1</bold>)</title><p>To a solution\nof <bold>L1</bold> (0.066 g, 0.15 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added [AuCl\u00ad(tht)] (0.048 g, 0.15 mmol), and the mixture\nwas stirred for 1 h. Then, the solution was evaporated to ca. 5 mL\nand hexane (15 mL) was added to obtain a yellow solid: 88% yield (0.088\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.71 (m, 4H,\nPh), 7.48 (m, 6H, Ph), 6.23 (m, br, 1H, NH), 4.67 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.37 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.21 (s, 5H, Cp), 3.68 (m, br, 2H, \u2212CH<sub>2</sub>N\u2212),\n2.87 (m, br, 2H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.21 (C\ue5fbO),\n133.34 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.3\nHz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 132.37 (<italic toggle=\"yes\">p</italic>-C<sub>5</sub>H<sub>6</sub>), 129.63 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.7 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 128.76 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 61.7 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 75.13 (C<sub>ipso</sub>), 70.95, 68.39 (C<sub>5</sub>H<sub>4</sub>), 69.90 (Cp), 36.38 (d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 5.6 Hz, \u2212CH<sub>2</sub>N\u2212), 28.72 (d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 37.7 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 24.32.\nMS (FAB<sup>+</sup>): [M]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 673 (48.18%), [M \u2013 Cl]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 638 (100%). Anal. Calcd for C<sub>25</sub>H<sub>24</sub>AuClFeNOP (673.7): C, 44.57; H, 3.59; N, 2.08. Found C, 44.73; H,\n3.54; N, 2.19.</p><title>Synthesis of [Ag\u00ad(OTf)\u00ad(<bold>L1</bold>)<sub>2</sub>] (<bold>2</bold>)</title><p>\n<italic toggle=\"yes\">Caution!</italic> Reactions\nwith silver salts should be protected from the light. To a solution\nof <bold>L1</bold> (0.1058 g, 0.24 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added [AgOTf] (0.0308 g, 0.12 mmol), and the mixture\nwas stirred for 1 h. Afterward the solution was evaporated to ca.\n5 mL and hexane was added (15 mL) to obtain a yellow solid: 73% yield\n(0.0997 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.59\u20137.23\n(m, 22H, Ph, NH), 4.80 (m, 4H, \u03b2-C<sub>5</sub>H<sub>4</sub>),\n4.29 (m, 4H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.18 (s, 10H, Cp),\n3.54 (m, br, 4H, \u2212CH<sub>2</sub>N\u2212), 2.72 (m, br, 4H,\n\u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR\n(CDCl<sub>3</sub>) \u03b4 (ppm): 132.88 (<italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.12 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.47 (<italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>),\n70.96, 68.67 (C<sub>5</sub>H<sub>4</sub>), 69.87 (Cp), 36.43 (\u2212CH<sub>2</sub>N\u2212), 27.29 (\u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, \u221260 \u00b0C)\n\u03b4 (ppm): 2.42 (2d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013Ag</sub> =\n577.0, 501.1 Hz). <sup>19</sup>F\u00ad{<sup>1</sup>H}-NMR (CDCl<sub>3</sub>) \u03b4 (ppm): \u221277.74. MS (FAB<sup>+</sup>): [M]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 989 (35%). Anal. Calcd for\nC<sub>55</sub>H<sub>48</sub>AgF<sub>3</sub>Fe<sub>2</sub>N<sub>2</sub>O<sub>5</sub>P<sub>2</sub>S (1139.5): C, 53.76, H, 4.25, N, 2.46;\nS, 2.81. Found: C, 53.46, H, 4.28, N, 2.42; S, 3.09.</p><title>Synthesis\nof [Ag\u00ad(OTf)\u00ad(<bold>L1</bold>)\u00ad(PPh<sub>3</sub>)] (<bold>3</bold>)</title><p>\n<italic toggle=\"yes\">Caution!</italic> Reactions with silver salts should be\nprotected from the light. To a solution of <bold>L1</bold> (0.044\ng, 0.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added [Ag\u00ad(OTf)\u00ad(PPh<sub>3</sub>)] (0.0518 g, 0.1 mmol), and the mixture was stirred for 1\nh. Afterward the solution was evaporated to ca. 5 mL and hexane (15\nmL) was added to obtain a yellow solid: 87% yield (0.0835 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.73\u20137.29 (m,\n26H, Ph, NH), 4.75 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.15\n(m, 7H, \u03b1-C<sub>5</sub>H<sub>4</sub>, Cp), 3.66 (m, 2H, \u2212CH<sub>2</sub>N\u2212), 2.83 (m, 2H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.85\n(C\ue5fbO), 134.08 (<italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 133.13 (<italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.24\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 131.13 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.50 (<italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 129.38 (<italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 75.45 (C<sub>\n<italic toggle=\"yes\">ipso</italic>\n</sub>), 70.63, 68.59 (C<sub>5</sub>H<sub>4</sub>), 69.89 (Cp), 36.19 (\u2212CH<sub>2</sub>N\u2212),\n27.78 (\u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 12.89 (2d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013Ag</sub> = 571.03, 495.04 Hz), 11.32 (m), 2.46 (2d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013Ag</sub> = 577.11, 500.17 Hz), 1.25 (2d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013Ag</sub> = 572.59, 495.6 Hz). <sup>19</sup>F\u00ad NMR (CDCl<sub>3</sub>) \u03b4 (ppm): \u221277.68.\nMS (FAB<sup>+</sup>): [M]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 810 (30.4%), [M \u2013 PPh<sub>3</sub>]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 548 (100%). Anal. Calcd for C<sub>44</sub>H<sub>39</sub>AgF<sub>3</sub>FeNO<sub>4</sub>P<sub>2</sub>S (960.5): C,\n55.02; H, 4.09; N, 1.46; S, 3.34. Found C, 55.16; H, 4.09; N, 1.46;\nS, 3.44.</p><title>General Procedure for the Synthesis of Phosphinegold\u00ad(I) Thiolates\nand Thionucleobase Analogues</title><p>A suspension of thiol or thionucleobase (0.2 mmol) and K<sub>2</sub>CO<sub>3</sub> (1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was stirred for 30 min. Then, complex <bold>1</bold> (0.2 mmol) was added and this mixture was stirred overnight.\nThe solution was filtered, the solvent was evaporated to ca. 5 mL,\nand hexane was added (15 mL) to obtain a solid.</p><title>Synthesis of [Au\u00ad(2-thionicotinicacid)\u00ad(<bold>L1</bold>)] (<bold>4</bold>):</title><p>yellow solid, 65% yield (0.103\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 8.51 (d, <italic toggle=\"yes\">J</italic> = 7.2 Hz, 1H, H6), 8.40 (d, <italic toggle=\"yes\">J</italic> = 4.8 Hz,\n1H, H4), 7.73 (m, 4H, Ph), 7.49 (m, 6H, Ph), 7.13 (dd, <italic toggle=\"yes\">J</italic> = 7.8, 4.9 Hz, 1H, H5), 6.65 (m, br, 1H, NH), 4.69 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.34 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.21 (s, 5H, Cp), 3.71 (m, 2H, \u2212CH<sub>2</sub>N\u2212),\n3.10 \u2013 2.68 (m, 2H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.35\n(C\ue5fbO), 133.33 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.0 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 132.27\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.60 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 129.00 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 59.9 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 75.23 (C<sub>ipso</sub>), 70.81, 68.39 (C<sub>5</sub>H<sub>4</sub>), 69.91 (Cp), 36.46 (\u2212CH<sub>2</sub>N\u2212),\n28.78 (d, <italic toggle=\"yes\">J</italic> = 35.6 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 25.47.\nAnal. Calcd for C<sub>31</sub>H<sub>28</sub>AuFeN<sub>2</sub>O<sub>3</sub>PS (792.4): C, 46.99; H, 3.56; N, 3.54, S 4.05. Found: C,\n46.64; H, 3.49; N, 3.41; S,  3.79.</p><title>Synthesis of [Au\u00ad(2-thiocytosine)\u00ad(<bold>L1</bold>)] (<bold>5</bold>):</title><p>yellow solid, 73% yield (0.111\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.93 (s, 1H,\nNH), 7.84 (d, <italic toggle=\"yes\">J</italic> = 5.7 Hz, 1H, H6), 7.73 (m, 4H, Ph),\n7.45 (m, 6H, Ph), 6.07 (d, <italic toggle=\"yes\">J</italic> = 5.8 Hz, 1H, H5), 4.97\n(m, br, 2H, NH<sub>2</sub>), 4.71 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.26 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.13\n(s, 5H, Cp), 3.71 (m, 2H, \u2212CH<sub>2</sub>N\u2212), 2.92 (m,\n2H, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H}\nNMR (CDCl<sub>3</sub>) \u03b4 (ppm): 28.81. Anal. Calcd for C<sub>29</sub>H<sub>28</sub>AuFeN<sub>4</sub>OPS (764.4): C, 45.57; H,\n3.69; N, 7.33; S, 4.19. Found: C, 45.75; H, 3.83; N, 6.97; S, 3.89.</p><title>Synthesis of [Au\u00ad(2-thiouracil)\u00ad(<bold>L1</bold>)] (<bold>6</bold>):</title><p>yellow solid, 67% yield (0.102 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 10.42 (s, 1H, NH), 7.71 (m, 4H, Ph), 7.63\n(d, <italic toggle=\"yes\">J</italic> = 6.7 Hz, 1H, H6), 7.48 (m, 6H, Ph), 6.14 (d, <italic toggle=\"yes\">J</italic> = 6.6 Hz, 1H, H5), 4.69 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.29 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.14\n(s, 5H, Cp), 3.69 (m, 2H, \u2212CH<sub>2</sub>N\u2212), 2.93 (m,\n2H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H}\nNMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.52 (C\ue5fbO), 133.36\n(d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.2 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 132.13 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.63 (d, <sup>4</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 57.8 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 129.58 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 110.13\n(C5), 75.55 (C<sub>ipso</sub>), 70.74, 68.46 (C<sub>5</sub>H<sub>4</sub>), 69.84 (Cp), 36.51 (\u2212CH<sub>2</sub>N\u2212), 29.06 (d, <italic toggle=\"yes\">J</italic> = 36.8 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 28.82. Anal.\nCalcd for C<sub>29</sub>H<sub>27</sub>AuFeN<sub>3</sub>O<sub>2</sub>PS (765.4): C, 45.51; H, 3.56; N, 5.49; S, 4.19. Found: C, 45.47;\nH, 3.68; N, 5.20; S, 3.98.</p><title>Synthesis of [Au\u00ad(6-thiopurine)\u00ad(<bold>L1</bold>)] (<bold>7</bold>):</title><p>yellow solid. 58% yield (0.092 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 8.64 (s, 1H, H9),\n8.13 (m, br, 1H, NH), 8.03 (s, 1H, H5), 7.70 (m, 4H, Ph), 7.42 (m,\n6H, Ph), 4.69 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.16 (s,\n2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.11 (s, 5H, Cp), 3.71 (m,\n2H, \u2212CH<sub>2</sub>N\u2212), 2.87 (m, 2H, CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.55\n(C\ue5fbO), 133.43 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.1 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.97\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.50 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 75.64 (C<sub>ipso</sub>), 70.64, 68.54\n(C<sub>5</sub>H<sub>4</sub>), 69.86 (Cp). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 25.64. Anal. Calcd for C<sub>30</sub>H<sub>27</sub>AuFeN<sub>5</sub>OPS (789.4): C, 45.64; H,\n3.45; N, 8.87; S, 4.06; found. C 45.50; H, 3.40; N, 8.67; S, 3.85.</p><title>Synthesis of [Au<sub>2</sub>Cl<sub>2</sub>(<bold>L2</bold>)] (<bold>8</bold>)</title><p>To a solution of <bold>L2</bold> (0.1771 g, 0.15\nmmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added [AuCl\u00ad(tht)]\n(0.1282 g, 0.30 mmol), and the mixture was stirred for 1 h. Afterward,\nthe solution was evaporated to ca. 5 mL and hexane was added (15 mL)\nto obtain a yellow solid: 93% yield (0.094 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.73 (m, 8H, Ph), 7.54 (m, br, 12H, Ph),\n4.59 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.40 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.24 (s, 5H, Cp), 3.73 (m, br, 4H, \u2212CH<sub>2</sub>N\u2212), 2.80 (m, br, 4H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 133.37\n(d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.6 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 132.65 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.89 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 10.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 70.92, 70.47 (C<sub>5</sub>H<sub>4</sub>), 70.17\n(Cp). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4\n(ppm): 25.67, 22.24. MS (FAB<sup>+</sup>): [M]<sup>+</sup>\n<italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 1117 (45%). Anal. Calcd for C<sub>39</sub>H<sub>37</sub>Au<sub>2</sub>Cl<sub>2</sub>FeNOP<sub>2</sub> (673.7):\nC, 41.88; H, 3.33; N, 1.25. Found: C, 41.76; H, 3.47; N, 1.26.</p><title>[Au<sub>2</sub>(2-thiocytosine)<sub>2</sub>(<bold>L2</bold>)] (<bold>9</bold>):</title><p>yellow solid, 70% yield (0.182 g). <sup>1</sup>H NMR\n(CDCl<sub>3</sub>) \u03b4 (ppm): 7.85 (d, <italic toggle=\"yes\">J</italic> = 5.7\nHz, 2H, H6), 7.74 (m, 8H, Ph), 7.47 (m, 12H, Ph), 5.83 (d, <italic toggle=\"yes\">J</italic> = 5.5 Hz, 2H, H5), 5.13 (m, br, 4H, NH<sub>2</sub>), 4.46\n(m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.21 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.19 (s, 5H, Cp), 3.90 (m, br, 4H, \u2212CH<sub>2</sub>N\u2212), 2.80 (m, br, 4H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.73\n(C\ue5fbO), 162.13 (C4), 155.69 (C6), 133.47 (d, <italic toggle=\"yes\">J</italic> = 13.7 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 132.04\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.58 (d, <italic toggle=\"yes\">J</italic> = 11.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 100.45 (C5), 70.46, 70.35 (C<sub>5</sub>H<sub>4</sub>), 70.13\n(Cp). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (acetone, \u221285 \u00b0C)\n\u03b4 (ppm): 29.36, 27.97. Anal. Calcd for C<sub>47</sub>H<sub>45</sub>Au<sub>2</sub>FeN<sub>7</sub>OP<sub>2</sub>S<sub>2</sub> (1299.8):\nC, 43.43; H, 3.49; N, 7.54; S, 4.93. Found: C, 43.17; H, 3.32; N,\n7.39; S, 4.67.</p><title>[Au<sub>2</sub>(TG)<sub>2</sub>(<bold>L2</bold>)] (<bold>10</bold>):</title><p>yellow solid, 75% yield (0.265 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.74 (m, 8H, Ph),\n7.49 (m, 12H, Ph), 5.13 (m, 8H, H1, H4, H5, H6), 4.49 (m, 1H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.36 (m, 1H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.27 (m, 1H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 4.24 (m, 1H,\n\u03b1-C<sub>5</sub>H<sub>4</sub>), 4.20 (dd, <italic toggle=\"yes\">J</italic> =\n12.3, 4.8 Hz, 1H, \u2212CH<sub>2</sub>\u2212), 4.16 (s, 5H, Cp),\n4.09 (dd, <italic toggle=\"yes\">J</italic> = 12.2, 2.4 Hz, 1H, \u2212CH<sub>2</sub>\u2212), 3.76 (m, br, 6H, H3, \u2212CH<sub>2</sub>N\u2212),\n2.75 (m, br, 4H, \u2212CH<sub>2</sub>P\u2212), 2.01 (s, 6H, \u2212CH<sub>3</sub>), 1.96 (s, 6H, \u2212CH<sub>3</sub>), 1.92 (s, 6H, \u2212CH<sub>3</sub>), 1.86 (s, 6H, \u2212CH<sub>3</sub>). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 171.20 (N\u2013C\ue5fbO),\n170.88, 170.40, 169.86, 169.75 (O\u2013C\ue5fbO), 133.43 (t, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 14.2 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.69 (<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.55 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 9.4 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 129.50 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 10.1 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 83.42\n(C1), 77.83 (C6), 75.86 (C3), 74.26 (C5), 70.47, 70.44 (C<sub>5</sub>H<sub>4</sub>), 70.00 (Cp), 69.09 (C4), 62.96 (\u2212CH<sub>2</sub>\u2212), 21.26, 20.88, 20.83, 20.79 (\u2212CH<sub>3</sub>). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>, \u221260 \u00b0C)\n\u03b4 (ppm): 29.44, 27.11. Anal. Calcd for C<sub>67</sub>H<sub>75</sub>Au<sub>2</sub>FeNO<sub>19</sub>P<sub>2</sub>S<sub>2</sub> (1774.2):\nC, 45.36; H, 4.26; N, 0.79; S, 3.61. Found: C, 45.25; H, 4.21; N,\n0.96; S, 3.84.</p><title>[Au<sub>2</sub>(TG)<sub>2</sub>(\u03bc-<bold>L3</bold>)] (<bold>11</bold>):</title><p>yellow solid, 70% yield (0.253\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.76 (m, 8H,\nPh), 7.46 (m, 12H, Ph), 5.19 (m, 8H, H5, H6, H4, H1), 4.53 (m, 2H,\nCp), 4.45 (m, 2H, Cp), 4.32 (m, 2H, Cp), 4.26 (m, 2H, Cp), 4.23 (m,\n2H, \u2212CH<sub>2</sub>\u2212), 4.12 (m, 2H, \u2212CH<sub>2</sub>\u2212), 3.72 (m, 6H, H3, \u2212CH<sub>2</sub>N\u2212), 2.91\n(m, 4H, \u2212CH<sub>2</sub>P\u2212), 2.08 (s, 6H, COCH<sub>3</sub>), 2.03 (s, 6H, COCH<sub>3</sub>), 1.98 (s, 6H, COCH<sub>3</sub>),\n1.88 (s, 6H, COCH<sub>3</sub>). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR\n(CDCl<sub>3</sub>) \u03b4 (ppm): 170.95, 170.89, 170.48, 170.38,\n169.83 (C\ue5fbO), 133.44 (t, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.3 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.72 (d, <sup>4</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 3.1 Hz, <italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.48\n(d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 10.9 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 129.42 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.0 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 83.51 (C1), 78.12 (C6), 75.90 (C3), 74.31\n(C5), 71.59, 71.44, 69.94 (C<sub>5</sub>H<sub>4</sub>), 69.02 (C4),\n62.86 (\u2212CH<sub>2</sub>\u2212), 36.68 (\u2212CH<sub>2</sub>N\u2212), 28.39 (d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 31.2\nHz, \u2212CH<sub>2</sub>P\u2212), 21.46, 20.89, 20.83 (\u2212CH<sub>3</sub>\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 25.54. Anal. Calcd for C<sub>68</sub>H<sub>76</sub>Au<sub>2</sub>FeN<sub>2</sub>O<sub>20</sub>P<sub>2</sub>S<sub>2</sub> (1817.2): C 44.94; H, 4.22; N, 1.54; S, 3.53. Found: C, 44.93; H,\n3.90; N, 1.46; S, 3.59.</p><title>[Au<sub>2</sub>(2-thiocytosine)<sub>2</sub>(\u03bc-<bold>L3</bold>)] (<bold>12</bold>):</title><p>yellow solid,\n74% yield (0.198 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4\n(ppm): 8.30 (m, br, 2H, NH), 7.84 (d, <italic toggle=\"yes\">J</italic> = 5.8 Hz,\n2H, H6), 7.74 (m, 8H, Ph), 7.44 (m, 12H, Ph), 6.06 (d, <italic toggle=\"yes\">J</italic> = 5.8 Hz, 2H, H5), 4.71 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.19 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 3.71 (m, 4H,\n\u2212CH<sub>2</sub>N\u2212), 2.90 (m, 4H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H}-NMR (CDCl<sub>3</sub>)\n\u03b4 (ppm): 178.77 (C2), 170.92 (C\ue5fbO), 162.61 (C4), 155.28\n(C6), 133.49 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.2 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.84\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.46 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 8.1 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 100.65 (C5), 72.25, 70.24 (C<sub>5</sub>H<sub>4</sub>), 36.53 (\u2212CH<sub>2</sub>N\u2212), 28.80 (d, <italic toggle=\"yes\">J</italic> = 29.8 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 28.20. Anal.\nCalcd for C<sub>48</sub>H<sub>46</sub>Au<sub>2</sub>FeN<sub>8</sub>O<sub>2</sub>P<sub>2</sub>S<sub>2</sub> (1342.8): C, 42.93; H, 3.45;\nN, 8.34; S, 4.78. Found: C, 43.07; H, 3.68; N, 8.22; S, 4.61.</p><title>[Au<sub>2</sub>(2-thiouracil)<sub>2</sub>(\u03bc-dppf)] (<bold>14</bold>):</title><p>yellow solid, 85% yield\n(0.204 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.77\n(d, <italic toggle=\"yes\">J</italic> = 6.3 Hz, 2H, H6), 7.66 (m, 8H, Ph), 7.47 (m,\n12H, Ph), 6.22 (d, <italic toggle=\"yes\">J</italic> = 6.3 Hz, 2H, H5), 4.63 (m,\nbr, 4H, Cp), 4.12 (m, br, 4H, Cp). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR\n(CDCl<sub>3</sub>) \u03b4 (ppm): 154.41 (C6), 133.91 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.9 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.82 (d, <sup>4</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 2.3 Hz, <italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 131.16 (d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 61.0 Hz, <italic toggle=\"yes\">ipso</italic>-C<sub>6</sub>H<sub>5</sub>), 129.17\n(d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.7 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 110.42 (C5), 73.41 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 8.4 Hz, Cp), 71.44\n(d, <sup>1</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 66.3 Hz, <italic toggle=\"yes\">ipso</italic>-Cp). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 27.34. Anal. Calcd for C<sub>42</sub>H<sub>34</sub>Au<sub>2</sub>FeN<sub>4</sub>O<sub>2</sub>P<sub>2</sub>S<sub>2</sub> (1202.6): C, 41.95; H, 2.85; N, 4.66; S, 5.33. Found: C, 41.90;\nH, 2.92; N, 4.63; S, 5.30.</p>", "clean_text": "Synthesis of PPh2CH2CH2NHCOFc (L1)\n\nTo a solution of 2-(diphenylphosphino)ethylamine (46 \u03bcL, 0.2 mmol) in CH2Cl2 (20 mL) was added triethylamine (60 \u03bcL, 0.43 mmol); the solution was stirred for 10 min at room temperature, and then it was poured into an ice bath, a solution of chlorocarbonylferrocene in CH2Cl2 (20 mL) was added dropwise, and the mixture was stirred overnight. An aqueous solution of NaHCO3 (30 mL) was added, the two phases were separated, and anhydrous Na2SO4 was added to the organic phase for drying. The solvent was evaporated to ca. 5 mL, and hexane (20 mL) was added to obtain a yellow solid: 75% yield (0.066 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.47 (m, 4H, Ph), 7.36 (m, 6H, Ph), 5.92 (m, br, 1H, NH), 4.58 (m, 2H, \u03b2-C5H4), 4.31 (m, 2H, \u03b1-C5H4), 4.19 (s, 5H, Cp), 3.54 (m, 2H, -CH2N-), 2.40 (t, J = 7.1 Hz, 2H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 170.34 (C\ue5fbO), 137.70 (d, 1 J P-C = 11.4 Hz, ipso-C6H5), 132.91 (d, 2 J P-C = 18.7 Hz, o-C6H5), 129.07 (p-C6H5), 128.82 (d, 3 J P-C = 6.9 Hz, m-C6H5), 76.15 (Cipso), 70.48, 68.18 (C5H4), 69.89 (Cp), 36.99 (d, 2 J    C-P = 18.8 Hz, -CH2N-), 28.93 (d, 1 J    C-P = 12.6 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): -20.93. MS (FAB+): m/z 442 (100%). Anal. Calcd for C25H24FeNOP (441.3): C, 68.04; H, 5.48; N, 3.17. Found: C, 67.82; H, 5.45; N, 3.29.\n\nSynthesis of (PPh2CH2CH2)2NCOFc (L2)\n\nTo a solution of bis[2-(diphenylphosphino)ethyl]amine (0.4777 g, 1 mmol) in CH2Cl2 (50 mL) was added triethylamine (300 \u03bcL, 2.1 mmol); the solution was stirred for 10 min at room temperature and then poured into an ice bath, a solution of chlorocarbonylferrocene in CH2Cl2 (20 mL) was added dropwise, and the mixture was then stirred overnight. An aqueous solution of NaHCO3 (30 mL) was added, the two phases were separated, and anhydrous Na2SO4 was added to the organic phase. The solvent was evaporated to ca. 15 mL, and hexane (40 mL) was added to obtain a white solid: 85% yield (0.555 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.38 (m, 20H), 4.37 (m, 2H, \u03b2-C5H4), 4.18 (m, 2H, \u03b1-C5H4), 4.13 (s, 5H, Cp), 3.51 (m, 4H, -CH2N-), 2.33 (m, 4H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 170.33 (C\ue5fbO), 132.88 (d, 2 J P-C = 18.8 Hz, o-C6H5), 128.77 (d, 3 J P-C = 6.4 Hz, m-C6H5), 70.43, 69.77 (C5H4), 69.84 (Cp). 31P{1H} NMR (CDCl3) \u03b4 (ppm): -20.11, -21.54. MS (FAB+): m/z 654 (50%). Anal. Calcd for C39H37FeNOP2 (653.5): C, 71.68; H, 5.71; N, 2.14. Found: C, 71.76; H, 5.27; N, 1.96.\n\nSynthesis of [AuCl(L1)] (1)\n\nTo a solution of L1 (0.066 g, 0.15 mmol) in CH2Cl2 (20 mL) was added [AuCl(tht)] (0.048 g, 0.15 mmol), and the mixture was stirred for 1 h. Then, the solution was evaporated to ca. 5 mL and hexane (15 mL) was added to obtain a yellow solid: 88% yield (0.088 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.71 (m, 4H, Ph), 7.48 (m, 6H, Ph), 6.23 (m, br, 1H, NH), 4.67 (m, 2H, \u03b2-C5H4), 4.37 (m, 2H, \u03b1-C5H4), 4.21 (s, 5H, Cp), 3.68 (m, br, 2H, -CH2N-), 2.87 (m, br, 2H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.21 (C\ue5fbO), 133.34 (d, 2 J P-C = 13.3 Hz, o-C6H5), 132.37 (p-C5H6), 129.63 (d, 3 J P-C = 11.7 Hz, m-C6H5), 128.76 (d, 1 J P-C = 61.7 Hz, ipso-C6H5), 75.13 (Cipso), 70.95, 68.39 (C5H4), 69.90 (Cp), 36.38 (d, J P-C = 5.6 Hz, -CH2N-), 28.72 (d, J P-C = 37.7 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 24.32. MS (FAB+): [M]+ m/z 673 (48.18%), [M - Cl]+ m/z 638 (100%). Anal. Calcd for C25H24AuClFeNOP (673.7): C, 44.57; H, 3.59; N, 2.08. Found C, 44.73; H, 3.54; N, 2.19.\n\nSynthesis of [Ag(OTf)(L1)2] (2)\n\n Caution! Reactions with silver salts should be protected from the light. To a solution of L1 (0.1058 g, 0.24 mmol) in CH2Cl2 (20 mL) was added [AgOTf] (0.0308 g, 0.12 mmol), and the mixture was stirred for 1 h. Afterward the solution was evaporated to ca. 5 mL and hexane was added (15 mL) to obtain a yellow solid: 73% yield (0.0997 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.59-7.23 (m, 22H, Ph, NH), 4.80 (m, 4H, \u03b2-C5H4), 4.29 (m, 4H, \u03b1-C5H4), 4.18 (s, 10H, Cp), 3.54 (m, br, 4H, -CH2N-), 2.72 (m, br, 4H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 132.88 (o-C6H5), 131.12 (p-C6H5), 129.47 (m-C6H5), 70.96, 68.67 (C5H4), 69.87 (Cp), 36.43 (-CH2N-), 27.29 (-CH2P-). 31P{1H} NMR (CDCl3, -60 \u00b0C) \u03b4 (ppm): 2.42 (2d, J P-Ag = 577.0, 501.1 Hz). 19F{1H}-NMR (CDCl3) \u03b4 (ppm): -77.74. MS (FAB+): [M]+ m/z 989 (35%). Anal. Calcd for C55H48AgF3Fe2N2O5P2S (1139.5): C, 53.76, H, 4.25, N, 2.46; S, 2.81. Found: C, 53.46, H, 4.28, N, 2.42; S, 3.09.\n\nSynthesis of [Ag(OTf)(L1)(PPh3)] (3)\n\n Caution! Reactions with silver salts should be protected from the light. To a solution of L1 (0.044 g, 0.1 mmol) in CH2Cl2 (20 mL) was added [Ag(OTf)(PPh3)] (0.0518 g, 0.1 mmol), and the mixture was stirred for 1 h. Afterward the solution was evaporated to ca. 5 mL and hexane (15 mL) was added to obtain a yellow solid: 87% yield (0.0835 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.73-7.29 (m, 26H, Ph, NH), 4.75 (m, 2H, \u03b2-C5H4), 4.15 (m, 7H, \u03b1-C5H4, Cp), 3.66 (m, 2H, -CH2N-), 2.83 (m, 2H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.85 (C\ue5fbO), 134.08 (o-C6H5), 133.13 (o-C6H5), 131.24 (p-C6H5), 131.13 (p-C6H5), 129.50 (m-C6H5), 129.38 (m-C6H5), 75.45 (C ipso ), 70.63, 68.59 (C5H4), 69.89 (Cp), 36.19 (-CH2N-), 27.78 (-CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 12.89 (2d, J P-Ag = 571.03, 495.04 Hz), 11.32 (m), 2.46 (2d, J P-Ag = 577.11, 500.17 Hz), 1.25 (2d, J P-Ag = 572.59, 495.6 Hz). 19F NMR (CDCl3) \u03b4 (ppm): -77.68. MS (FAB+): [M]+ m/z 810 (30.4%), [M - PPh3]+ m/z 548 (100%). Anal. Calcd for C44H39AgF3FeNO4P2S (960.5): C, 55.02; H, 4.09; N, 1.46; S, 3.34. Found C, 55.16; H, 4.09; N, 1.46; S, 3.44.\n\nGeneral Procedure for the Synthesis of Phosphinegold(I) Thiolates and Thionucleobase Analogues\n\nA suspension of thiol or thionucleobase (0.2 mmol) and K2CO3 (1 mmol) in CH2Cl2 (15 mL) was stirred for 30 min. Then, complex 1 (0.2 mmol) was added and this mixture was stirred overnight. The solution was filtered, the solvent was evaporated to ca. 5 mL, and hexane was added (15 mL) to obtain a solid.\n\nSynthesis of [Au(2-thionicotinicacid)(L1)] (4):\n\nyellow solid, 65% yield (0.103 g). 1H NMR (CDCl3) \u03b4 (ppm): 8.51 (d, J = 7.2 Hz, 1H, H6), 8.40 (d, J = 4.8 Hz, 1H, H4), 7.73 (m, 4H, Ph), 7.49 (m, 6H, Ph), 7.13 (dd, J = 7.8, 4.9 Hz, 1H, H5), 6.65 (m, br, 1H, NH), 4.69 (m, 2H, \u03b2-C5H4), 4.34 (m, 2H, \u03b1-C5H4), 4.21 (s, 5H, Cp), 3.71 (m, 2H, -CH2N-), 3.10 - 2.68 (m, 2H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.35 (C\ue5fbO), 133.33 (d, 2 J P-C = 13.0 Hz, o-C6H5), 132.27 (p-C6H5), 129.60 (d, 3 J P-C = 11.4 Hz, m-C6H5), 129.00 (d, 1 J P-C = 59.9 Hz, ipso-C6H5), 75.23 (Cipso), 70.81, 68.39 (C5H4), 69.91 (Cp), 36.46 (-CH2N-), 28.78 (d, J = 35.6 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 25.47. Anal. Calcd for C31H28AuFeN2O3PS (792.4): C, 46.99; H, 3.56; N, 3.54, S 4.05. Found: C, 46.64; H, 3.49; N, 3.41; S,  3.79.\n\nSynthesis of [Au(2-thiocytosine)(L1)] (5):\n\nyellow solid, 73% yield (0.111 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.93 (s, 1H, NH), 7.84 (d, J = 5.7 Hz, 1H, H6), 7.73 (m, 4H, Ph), 7.45 (m, 6H, Ph), 6.07 (d, J = 5.8 Hz, 1H, H5), 4.97 (m, br, 2H, NH2), 4.71 (m, 2H, \u03b2-C5H4), 4.26 (m, 2H, \u03b1-C5H4), 4.13 (s, 5H, Cp), 3.71 (m, 2H, -CH2N-), 2.92 (m, 2H, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 28.81. Anal. Calcd for C29H28AuFeN4OPS (764.4): C, 45.57; H, 3.69; N, 7.33; S, 4.19. Found: C, 45.75; H, 3.83; N, 6.97; S, 3.89.\n\nSynthesis of [Au(2-thiouracil)(L1)] (6):\n\nyellow solid, 67% yield (0.102 g). 1H NMR (CDCl3) \u03b4 (ppm): 10.42 (s, 1H, NH), 7.71 (m, 4H, Ph), 7.63 (d, J = 6.7 Hz, 1H, H6), 7.48 (m, 6H, Ph), 6.14 (d, J = 6.6 Hz, 1H, H5), 4.69 (m, 2H, \u03b2-C5H4), 4.29 (m, 2H, \u03b1-C5H4), 4.14 (s, 5H, Cp), 3.69 (m, 2H, -CH2N-), 2.93 (m, 2H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.52 (C\ue5fbO), 133.36 (d, 2 J P-C = 13.2 Hz, o-C6H5), 132.13 (p-C6H5), 129.63 (d, 4 J P-C = 57.8 Hz, ipso-C6H5), 129.58 (d, 3 J P-C = 11.4 Hz, m-C6H5), 110.13 (C5), 75.55 (Cipso), 70.74, 68.46 (C5H4), 69.84 (Cp), 36.51 (-CH2N-), 29.06 (d, J = 36.8 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 28.82. Anal. Calcd for C29H27AuFeN3O2PS (765.4): C, 45.51; H, 3.56; N, 5.49; S, 4.19. Found: C, 45.47; H, 3.68; N, 5.20; S, 3.98.\n\nSynthesis of [Au(6-thiopurine)(L1)] (7):\n\nyellow solid. 58% yield (0.092 g). 1H NMR (CDCl3) \u03b4 (ppm): 8.64 (s, 1H, H9), 8.13 (m, br, 1H, NH), 8.03 (s, 1H, H5), 7.70 (m, 4H, Ph), 7.42 (m, 6H, Ph), 4.69 (m, 2H, \u03b2-C5H4), 4.16 (s, 2H, \u03b1-C5H4), 4.11 (s, 5H, Cp), 3.71 (m, 2H, -CH2N-), 2.87 (m, 2H, CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.55 (C\ue5fbO), 133.43 (d, 2 J P-C = 13.1 Hz, o-C6H5), 131.97 (p-C6H5), 129.50 (d, 3 J P-C = 11.4 Hz, m-C6H5), 75.64 (Cipso), 70.64, 68.54 (C5H4), 69.86 (Cp). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 25.64. Anal. Calcd for C30H27AuFeN5OPS (789.4): C, 45.64; H, 3.45; N, 8.87; S, 4.06; found. C 45.50; H, 3.40; N, 8.67; S, 3.85.\n\nSynthesis of [Au2Cl2(L2)] (8)\n\nTo a solution of L2 (0.1771 g, 0.15 mmol) in CH2Cl2 (20 mL) was added [AuCl(tht)] (0.1282 g, 0.30 mmol), and the mixture was stirred for 1 h. Afterward, the solution was evaporated to ca. 5 mL and hexane was added (15 mL) to obtain a yellow solid: 93% yield (0.094 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.73 (m, 8H, Ph), 7.54 (m, br, 12H, Ph), 4.59 (m, 2H, \u03b2-C5H4), 4.40 (m, 2H, \u03b1-C5H4), 4.24 (s, 5H, Cp), 3.73 (m, br, 4H, -CH2N-), 2.80 (m, br, 4H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 133.37 (d, 2 J P-C = 13.6 Hz, o-C6H5), 132.65 (p-C6H5), 129.89 (d, 3 J P-C = 10.4 Hz, m-C6H5), 70.92, 70.47 (C5H4), 70.17 (Cp). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 25.67, 22.24. MS (FAB+): [M]+ m/z 1117 (45%). Anal. Calcd for C39H37Au2Cl2FeNOP2 (673.7): C, 41.88; H, 3.33; N, 1.25. Found: C, 41.76; H, 3.47; N, 1.26.\n\n[Au2(2-thiocytosine)2(L2)] (9):\n\nyellow solid, 70% yield (0.182 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.85 (d, J = 5.7 Hz, 2H, H6), 7.74 (m, 8H, Ph), 7.47 (m, 12H, Ph), 5.83 (d, J = 5.5 Hz, 2H, H5), 5.13 (m, br, 4H, NH2), 4.46 (m, 2H, \u03b2-C5H4), 4.21 (m, 2H, \u03b1-C5H4), 4.19 (s, 5H, Cp), 3.90 (m, br, 4H, -CH2N-), 2.80 (m, br, 4H, -CH2P-). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.73 (C\ue5fbO), 162.13 (C4), 155.69 (C6), 133.47 (d, J = 13.7 Hz, o-C6H5), 132.04 (p-C6H5), 129.58 (d, J = 11.4 Hz, m-C6H5), 100.45 (C5), 70.46, 70.35 (C5H4), 70.13 (Cp). 31P{1H} NMR (acetone, -85 \u00b0C) \u03b4 (ppm): 29.36, 27.97. Anal. Calcd for C47H45Au2FeN7OP2S2 (1299.8): C, 43.43; H, 3.49; N, 7.54; S, 4.93. Found: C, 43.17; H, 3.32; N, 7.39; S, 4.67.\n\n[Au2(TG)2(L2)] (10):\n\nyellow solid, 75% yield (0.265 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.74 (m, 8H, Ph), 7.49 (m, 12H, Ph), 5.13 (m, 8H, H1, H4, H5, H6), 4.49 (m, 1H, \u03b2-C5H4), 4.36 (m, 1H, \u03b2-C5H4), 4.27 (m, 1H, \u03b1-C5H4), 4.24 (m, 1H, \u03b1-C5H4), 4.20 (dd, J = 12.3, 4.8 Hz, 1H, -CH2-), 4.16 (s, 5H, Cp), 4.09 (dd, J = 12.2, 2.4 Hz, 1H, -CH2-), 3.76 (m, br, 6H, H3, -CH2N-), 2.75 (m, br, 4H, -CH2P-), 2.01 (s, 6H, -CH3), 1.96 (s, 6H, -CH3), 1.92 (s, 6H, -CH3), 1.86 (s, 6H, -CH3). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 171.20 (N-C\ue5fbO), 170.88, 170.40, 169.86, 169.75 (O-C\ue5fbO), 133.43 (t, 2 J P-C = 14.2 Hz, o-C6H5), 131.69 (p-C6H5), 129.55 (d, 3 J P-C = 9.4 Hz, m-C6H5), 129.50 (d, 3 J P-C = 10.1 Hz, m-C6H5), 83.42 (C1), 77.83 (C6), 75.86 (C3), 74.26 (C5), 70.47, 70.44 (C5H4), 70.00 (Cp), 69.09 (C4), 62.96 (-CH2-), 21.26, 20.88, 20.83, 20.79 (-CH3). 31P{1H} NMR (CDCl3, -60 \u00b0C) \u03b4 (ppm): 29.44, 27.11. Anal. Calcd for C67H75Au2FeNO19P2S2 (1774.2): C, 45.36; H, 4.26; N, 0.79; S, 3.61. Found: C, 45.25; H, 4.21; N, 0.96; S, 3.84.\n\n[Au2(TG)2(\u03bc-L3)] (11):\n\nyellow solid, 70% yield (0.253 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.76 (m, 8H, Ph), 7.46 (m, 12H, Ph), 5.19 (m, 8H, H5, H6, H4, H1), 4.53 (m, 2H, Cp), 4.45 (m, 2H, Cp), 4.32 (m, 2H, Cp), 4.26 (m, 2H, Cp), 4.23 (m, 2H, -CH2-), 4.12 (m, 2H, -CH2-), 3.72 (m, 6H, H3, -CH2N-), 2.91 (m, 4H, -CH2P-), 2.08 (s, 6H, COCH3), 2.03 (s, 6H, COCH3), 1.98 (s, 6H, COCH3), 1.88 (s, 6H, COCH3). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 170.95, 170.89, 170.48, 170.38, 169.83 (C\ue5fbO), 133.44 (t, 2 J P-C = 13.3 Hz, o-C6H5), 131.72 (d, 4 J P-C = 3.1 Hz, p-C6H5), 129.48 (d, 3 J P-C = 10.9 Hz, m-C6H5), 129.42 (d, 3 J P-C = 11.0 Hz, m-C6H5), 83.51 (C1), 78.12 (C6), 75.90 (C3), 74.31 (C5), 71.59, 71.44, 69.94 (C5H4), 69.02 (C4), 62.86 (-CH2-), 36.68 (-CH2N-), 28.39 (d, J P-C = 31.2 Hz, -CH2P-), 21.46, 20.89, 20.83 (-CH3-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 25.54. Anal. Calcd for C68H76Au2FeN2O20P2S2 (1817.2): C 44.94; H, 4.22; N, 1.54; S, 3.53. Found: C, 44.93; H, 3.90; N, 1.46; S, 3.59.\n\n[Au2(2-thiocytosine)2(\u03bc-L3)] (12):\n\nyellow solid, 74% yield (0.198 g). 1H NMR (CDCl3) \u03b4 (ppm): 8.30 (m, br, 2H, NH), 7.84 (d, J = 5.8 Hz, 2H, H6), 7.74 (m, 8H, Ph), 7.44 (m, 12H, Ph), 6.06 (d, J = 5.8 Hz, 2H, H5), 4.71 (m, 2H, \u03b2-C5H4), 4.19 (m, 2H, \u03b1-C5H4), 3.71 (m, 4H, -CH2N-), 2.90 (m, 4H, -CH2P-). 13C{1H}-NMR (CDCl3) \u03b4 (ppm): 178.77 (C2), 170.92 (C\ue5fbO), 162.61 (C4), 155.28 (C6), 133.49 (d, 2 J P-C = 11.2 Hz, o-C6H5), 131.84 (p-C6H5), 129.46 (d, 3 J P-C = 8.1 Hz, m-C6H5), 100.65 (C5), 72.25, 70.24 (C5H4), 36.53 (-CH2N-), 28.80 (d, J = 29.8 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 28.20. Anal. Calcd for C48H46Au2FeN8O2P2S2 (1342.8): C, 42.93; H, 3.45; N, 8.34; S, 4.78. Found: C, 43.07; H, 3.68; N, 8.22; S, 4.61.\n\n[Au2(2-thiouracil)2(\u03bc-dppf)] (14):\n\nyellow solid, 85% yield (0.204 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.77 (d, J = 6.3 Hz, 2H, H6), 7.66 (m, 8H, Ph), 7.47 (m, 12H, Ph), 6.22 (d, J = 6.3 Hz, 2H, H5), 4.63 (m, br, 4H, Cp), 4.12 (m, br, 4H, Cp). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 154.41 (C6), 133.91 (d, 2 J P-C = 13.9 Hz, o-C6H5), 131.82 (d, 4 J P-C = 2.3 Hz, p-C6H5), 131.16 (d, 1 J P-C = 61.0 Hz, ipso-C6H5), 129.17 (d, 2 J P-C = 11.7 Hz, m-C6H5), 110.42 (C5), 73.41 (d, 3 J P-C = 8.4 Hz, Cp), 71.44 (d, 1 J P-C = 66.3 Hz, ipso-Cp). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 27.34. Anal. Calcd for C42H34Au2FeN4O2P2S2 (1202.6): C, 41.95; H, 2.85; N, 4.66; S, 5.33. Found: C, 41.90; H, 2.92; N, 4.63; S, 5.30.", "data": [["This model's maximum context length is 8192 tokens. However, your messages resulted in 10720 tokens. Please reduce the length of the messages."]], "include_properties": ["filtration", "chemical_synthesis"], "intermediate_step": {"text-synthesis-type": "[]", "text-synthesis-struct": "This model's maximum context length is 8192 tokens. However, your messages resulted in 10720 tokens. Please reduce the length of the messages."}}, {"idx": "52, 53", "type": "text", "classification": "property", "content": "<title>[Au<sub>2</sub>(TG)<sub>2</sub>(\u03bc-<bold>L3</bold>)] (<bold>11</bold>):</title><p>yellow solid, 70% yield (0.253\ng). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 7.76 (m, 8H,\nPh), 7.46 (m, 12H, Ph), 5.19 (m, 8H, H5, H6, H4, H1), 4.53 (m, 2H,\nCp), 4.45 (m, 2H, Cp), 4.32 (m, 2H, Cp), 4.26 (m, 2H, Cp), 4.23 (m,\n2H, \u2212CH<sub>2</sub>\u2212), 4.12 (m, 2H, \u2212CH<sub>2</sub>\u2212), 3.72 (m, 6H, H3, \u2212CH<sub>2</sub>N\u2212), 2.91\n(m, 4H, \u2212CH<sub>2</sub>P\u2212), 2.08 (s, 6H, COCH<sub>3</sub>), 2.03 (s, 6H, COCH<sub>3</sub>), 1.98 (s, 6H, COCH<sub>3</sub>),\n1.88 (s, 6H, COCH<sub>3</sub>). <sup>13</sup>C\u00ad{<sup>1</sup>H} NMR\n(CDCl<sub>3</sub>) \u03b4 (ppm): 170.95, 170.89, 170.48, 170.38,\n169.83 (C\ue5fbO), 133.44 (t, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 13.3 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.72 (d, <sup>4</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 3.1 Hz, <italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.48\n(d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 10.9 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 129.42 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.0 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 83.51 (C1), 78.12 (C6), 75.90 (C3), 74.31\n(C5), 71.59, 71.44, 69.94 (C<sub>5</sub>H<sub>4</sub>), 69.02 (C4),\n62.86 (\u2212CH<sub>2</sub>\u2212), 36.68 (\u2212CH<sub>2</sub>N\u2212), 28.39 (d, <italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 31.2\nHz, \u2212CH<sub>2</sub>P\u2212), 21.46, 20.89, 20.83 (\u2212CH<sub>3</sub>\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 25.54. Anal. Calcd for C<sub>68</sub>H<sub>76</sub>Au<sub>2</sub>FeN<sub>2</sub>O<sub>20</sub>P<sub>2</sub>S<sub>2</sub> (1817.2): C 44.94; H, 4.22; N, 1.54; S, 3.53. Found: C, 44.93; H,\n3.90; N, 1.46; S, 3.59.</p><title>[Au<sub>2</sub>(2-thiocytosine)<sub>2</sub>(\u03bc-<bold>L3</bold>)] (<bold>12</bold>):</title><p>yellow solid,\n74% yield (0.198 g). <sup>1</sup>H NMR (CDCl<sub>3</sub>) \u03b4\n(ppm): 8.30 (m, br, 2H, NH), 7.84 (d, <italic toggle=\"yes\">J</italic> = 5.8 Hz,\n2H, H6), 7.74 (m, 8H, Ph), 7.44 (m, 12H, Ph), 6.06 (d, <italic toggle=\"yes\">J</italic> = 5.8 Hz, 2H, H5), 4.71 (m, 2H, \u03b2-C<sub>5</sub>H<sub>4</sub>), 4.19 (m, 2H, \u03b1-C<sub>5</sub>H<sub>4</sub>), 3.71 (m, 4H,\n\u2212CH<sub>2</sub>N\u2212), 2.90 (m, 4H, \u2212CH<sub>2</sub>P\u2212). <sup>13</sup>C\u00ad{<sup>1</sup>H}-NMR (CDCl<sub>3</sub>)\n\u03b4 (ppm): 178.77 (C2), 170.92 (C\ue5fbO), 162.61 (C4), 155.28\n(C6), 133.49 (d, <sup>2</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 11.2 Hz, <italic toggle=\"yes\">o</italic>-C<sub>6</sub>H<sub>5</sub>), 131.84\n(<italic toggle=\"yes\">p</italic>-C<sub>6</sub>H<sub>5</sub>), 129.46 (d, <sup>3</sup>\n<italic toggle=\"yes\">J</italic>\n<sub>P\u2013C</sub> = 8.1 Hz, <italic toggle=\"yes\">m</italic>-C<sub>6</sub>H<sub>5</sub>), 100.65 (C5), 72.25, 70.24 (C<sub>5</sub>H<sub>4</sub>), 36.53 (\u2212CH<sub>2</sub>N\u2212), 28.80 (d, <italic toggle=\"yes\">J</italic> = 29.8 Hz, \u2212CH<sub>2</sub>P\u2212). <sup>31</sup>P\u00ad{<sup>1</sup>H} NMR (CDCl<sub>3</sub>) \u03b4 (ppm): 28.20. Anal.\nCalcd for C<sub>48</sub>H<sub>46</sub>Au<sub>2</sub>FeN<sub>8</sub>O<sub>2</sub>P<sub>2</sub>S<sub>2</sub> (1342.8): C, 42.93; H, 3.45;\nN, 8.34; S, 4.78. Found: C, 43.07; H, 3.68; N, 8.22; S, 4.61.</p>", "clean_text": "[Au2(TG)2(\u03bc-L3)] (11):\n\nyellow solid, 70% yield (0.253 g). 1H NMR (CDCl3) \u03b4 (ppm): 7.76 (m, 8H, Ph), 7.46 (m, 12H, Ph), 5.19 (m, 8H, H5, H6, H4, H1), 4.53 (m, 2H, Cp), 4.45 (m, 2H, Cp), 4.32 (m, 2H, Cp), 4.26 (m, 2H, Cp), 4.23 (m, 2H, -CH2-), 4.12 (m, 2H, -CH2-), 3.72 (m, 6H, H3, -CH2N-), 2.91 (m, 4H, -CH2P-), 2.08 (s, 6H, COCH3), 2.03 (s, 6H, COCH3), 1.98 (s, 6H, COCH3), 1.88 (s, 6H, COCH3). 13C{1H} NMR (CDCl3) \u03b4 (ppm): 170.95, 170.89, 170.48, 170.38, 169.83 (C\ue5fbO), 133.44 (t, 2 J P-C = 13.3 Hz, o-C6H5), 131.72 (d, 4 J P-C = 3.1 Hz, p-C6H5), 129.48 (d, 3 J P-C = 10.9 Hz, m-C6H5), 129.42 (d, 3 J P-C = 11.0 Hz, m-C6H5), 83.51 (C1), 78.12 (C6), 75.90 (C3), 74.31 (C5), 71.59, 71.44, 69.94 (C5H4), 69.02 (C4), 62.86 (-CH2-), 36.68 (-CH2N-), 28.39 (d, J P-C = 31.2 Hz, -CH2P-), 21.46, 20.89, 20.83 (-CH3-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 25.54. Anal. Calcd for C68H76Au2FeN2O20P2S2 (1817.2): C 44.94; H, 4.22; N, 1.54; S, 3.53. Found: C, 44.93; H, 3.90; N, 1.46; S, 3.59.\n\n[Au2(2-thiocytosine)2(\u03bc-L3)] (12):\n\nyellow solid, 74% yield (0.198 g). 1H NMR (CDCl3) \u03b4 (ppm): 8.30 (m, br, 2H, NH), 7.84 (d, J = 5.8 Hz, 2H, H6), 7.74 (m, 8H, Ph), 7.44 (m, 12H, Ph), 6.06 (d, J = 5.8 Hz, 2H, H5), 4.71 (m, 2H, \u03b2-C5H4), 4.19 (m, 2H, \u03b1-C5H4), 3.71 (m, 4H, -CH2N-), 2.90 (m, 4H, -CH2P-). 13C{1H}-NMR (CDCl3) \u03b4 (ppm): 178.77 (C2), 170.92 (C\ue5fbO), 162.61 (C4), 155.28 (C6), 133.49 (d, 2 J P-C = 11.2 Hz, o-C6H5), 131.84 (p-C6H5), 129.46 (d, 3 J P-C = 8.1 Hz, m-C6H5), 100.65 (C5), 72.25, 70.24 (C5H4), 36.53 (-CH2N-), 28.80 (d, J = 29.8 Hz, -CH2P-). 31P{1H} NMR (CDCl3) \u03b4 (ppm): 28.20. Anal. Calcd for C48H46Au2FeN8O2P2S2 (1342.8): C, 42.93; H, 3.45; N, 8.34; S, 4.78. Found: C, 43.07; H, 3.68; N, 8.22; S, 4.61.", "data": [[[{"meta": {"name": "[Au2(TG)2(\u03bc-L3)] (11)", "symbol": "11", "chemical formula": "C68H76Au2FeN2O20P2S2"}, "material color": [{"value": "yellow", "condition": "solid"}], "chemical formula weight": [{"value": "1817.2", "unit": "g/mol", "condition": ""}]}, {"meta": {"name": "[Au2(2-thiocytosine)2(\u03bc-L3)] (12)", "symbol": "12", "chemical formula": "C48H46Au2FeN8O2P2S2"}, "material color": [{"value": "yellow", "condition": "solid"}], "chemical formula weight": [{"value": "1342.8", "unit": "g/mol", "condition": ""}]}]]], "include_properties": ["material_color", "chemical_formula_weight"], "intermediate_step": {"categorize": "['property', 'synthesis condition']", "text-property-type": "['material_color', 'chemical_formula_weight']", "text-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"[Au2(TG)2(\u03bc-L3)] (11)\",\n            \"symbol\": \"11\",\n            \"chemical formula\": \"C68H76Au2FeN2O20P2S2\"\n        },\n        \"material color\": [\n            {\n                \"value\": \"yellow\",\n                \"condition\": \"solid\"\n            }\n        ],\n        \"chemical formula weight\": [\n            {\n                \"value\": \"1817.2\",\n                \"unit\": \"g/mol\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"[Au2(2-thiocytosine)2(\u03bc-L3)] (12)\",\n            \"symbol\": \"12\",\n            \"chemical formula\": \"C48H46Au2FeN8O2P2S2\"\n        },\n        \"material color\": [\n            {\n                \"value\": \"yellow\",\n                \"condition\": \"solid\"\n            }\n        ],\n        \"chemical formula weight\": [\n            {\n                \"value\": \"1342.8\",\n                \"unit\": \"g/mol\",\n                \"condition\": \"\"\n            }\n        ]\n    }\n]\n```"}}, {"idx": 32, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\" nameend=\"col5\" namest=\"col2\" rowsep=\"1\">IC<sub>50</sub> (\u03bcM)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry align=\"center\">compd</oasis:entry>\n<oasis:entry align=\"center\">NIH-3T3</oasis:entry>\n<oasis:entry align=\"center\">PC-12</oasis:entry>\n<oasis:entry align=\"center\">A-549</oasis:entry>\n<oasis:entry align=\"center\">Hep-G2</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>L1</bold>\n</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>L2</bold>\n</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>0.1</oasis:entry>\n<oasis:entry>4.2</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>68</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry>23.3</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>21</oasis:entry>\n<oasis:entry>70.7</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>42.3</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>26.4</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>8</bold>\n</oasis:entry>\n<oasis:entry>11.4</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>29.9</oasis:entry>\n<oasis:entry>29.1</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>[Au<sub>2</sub>Cl<sub>2</sub>(\u03bc-<bold>L3</bold>)]</oasis:entry>\n<oasis:entry>14.5</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>[Au<sub>2</sub>Cl<sub>2</sub>(\u03bc-dppf)]</oasis:entry>\n<oasis:entry>9.8</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>8.2</oasis:entry>\n<oasis:entry>10.7</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 1. IC<sub>50</sub> values (\u03bcM) for compounds tested against different cell lines\n\n| compd | NIH-3T3 | PC-12 | A-549 | Hep-G2 |\n|-------|---------|-------|------|-------|\n| L1    | >100    | >100  | >100 | >100  |\n| L2    | >100    | >100  | >100 | >100  |\n| 1     | 0.1     | 4.2   | >100 | 68    |\n| 2     | 23.3    |       | 21   | 70.7  |\n| 3     | 42.3    |       | 26.4 | >100  |\n| 8     | 11.4    |       | 29.9 | 29.1  |\n| [Au<sub>2</sub>Cl<sub>2</sub>(\u03bc-L3)] | 14.5 | | >100 | >100 |\n| [Au<sub>2</sub>Cl<sub>2</sub>(\u03bc-dppf)] | 9.8 | | 8.2 | 10.7 |", "data": [[{"meta": {"name": "L1", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50 values for NIH-3T3", "value": ">100", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for PC-12", "value": ">100", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for A-549", "value": ">100", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for Hep-G2", "value": ">100", "unit": "\u03bcM", "condition": ""}]}, {"meta": {"name": "L2", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50 values for NIH-3T3", "value": ">100", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for PC-12", "value": ">100", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for A-549", "value": ">100", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for Hep-G2", "value": ">100", "unit": "\u03bcM", "condition": ""}]}, {"meta": {"name": "1", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50 values for NIH-3T3", "value": "0.1", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for PC-12", "value": "4.2", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for A-549", "value": ">100", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for Hep-G2", "value": "68", "unit": "\u03bcM", "condition": ""}]}, {"meta": {"name": "2", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50 values for NIH-3T3", "value": "23.3", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for A-549", "value": "21", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for Hep-G2", "value": "70.7", "unit": "\u03bcM", "condition": ""}]}, {"meta": {"name": "3", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50 values for NIH-3T3", "value": "42.3", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for A-549", "value": "26.4", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for Hep-G2", "value": ">100", "unit": "\u03bcM", "condition": ""}]}, {"meta": {"name": "8", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50 values for NIH-3T3", "value": "11.4", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for A-549", "value": "29.9", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for Hep-G2", "value": "29.1", "unit": "\u03bcM", "condition": ""}]}, {"meta": {"name": "[Au2Cl2(\u03bc-L3)]", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50 values for NIH-3T3", "value": "14.5", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for A-549", "value": ">100", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for Hep-G2", "value": ">100", "unit": "\u03bcM", "condition": ""}]}, {"meta": {"name": "[Au2Cl2(\u03bc-dppf)]", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50 values for NIH-3T3", "value": "9.8", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for A-549", "value": "8.2", "unit": "\u03bcM", "condition": ""}, {"property name": "IC50 values for Hep-G2", "value": "10.7", "unit": "\u03bcM", "condition": ""}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. IC<sub>50</sub> values (\u03bcM) for compounds tested against different cell lines\n\n| compd | NIH-3T3 | PC-12 | A-549 | Hep-G2 |\n|-------|---------|-------|------|-------|\n| L1    | >100    | >100  | >100 | >100  |\n| L2    | >100    | >100  | >100 | >100  |\n| 1     | 0.1     | 4.2   | >100 | 68    |\n| 2     | 23.3    |       | 21   | 70.7  |\n| 3     | 42.3    |       | 26.4 | >100  |\n| 8     | 11.4    |       | 29.9 | 29.1  |\n| [Au<sub>2</sub>Cl<sub>2</sub>(\u03bc-L3)] | 14.5 | | >100 | >100 |\n| [Au<sub>2</sub>Cl<sub>2</sub>(\u03bc-dppf)] | 9.8 | | 8.2 | 10.7 |\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"L1\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50 values for NIH-3T3\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for PC-12\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for A-549\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for Hep-G2\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"L2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50 values for NIH-3T3\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for PC-12\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for A-549\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for Hep-G2\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"1\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50 values for NIH-3T3\",\n                \"value\": \"0.1\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for PC-12\",\n                \"value\": \"4.2\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for A-549\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for Hep-G2\",\n                \"value\": \"68\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50 values for NIH-3T3\",\n                \"value\": \"23.3\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for A-549\",\n                \"value\": \"21\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for Hep-G2\",\n                \"value\": \"70.7\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"3\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50 values for NIH-3T3\",\n                \"value\": \"42.3\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for A-549\",\n                \"value\": \"26.4\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for Hep-G2\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"8\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50 values for NIH-3T3\",\n                \"value\": \"11.4\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for A-549\",\n                \"value\": \"29.9\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for Hep-G2\",\n                \"value\": \"29.1\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"[Au2Cl2(\u03bc-L3)]\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50 values for NIH-3T3\",\n                \"value\": \"14.5\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for A-549\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for Hep-G2\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"[Au2Cl2(\u03bc-dppf)]\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50 values for NIH-3T3\",\n                \"value\": \"9.8\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for A-549\",\n                \"value\": \"8.2\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"IC50 values for Hep-G2\",\n                \"value\": \"10.7\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 34, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\" nameend=\"col5\" namest=\"col2\" rowsep=\"1\">IC<sub>50</sub> (\u03bcM)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry align=\"center\" valign=\"top\">compd</oasis:entry>\n<oasis:entry align=\"center\" valign=\"top\">NIH-3T3</oasis:entry>\n<oasis:entry align=\"center\" valign=\"top\">PC-12</oasis:entry>\n<oasis:entry align=\"center\" valign=\"top\">A-549</oasis:entry>\n<oasis:entry align=\"center\" valign=\"top\">Hep-G2</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>0.2</oasis:entry>\n<oasis:entry>2.1</oasis:entry>\n<oasis:entry>12.6</oasis:entry>\n<oasis:entry>7.8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>5</bold>\n</oasis:entry>\n<oasis:entry>0.8</oasis:entry>\n<oasis:entry>2.4</oasis:entry>\n<oasis:entry>95.1</oasis:entry>\n<oasis:entry>&gt;100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>6</bold>\n</oasis:entry>\n<oasis:entry>2.0</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>15.0</oasis:entry>\n<oasis:entry>20.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>7</bold>\n</oasis:entry>\n<oasis:entry>13.7</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>21.0</oasis:entry>\n<oasis:entry>70.7</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>9</bold>\n</oasis:entry>\n<oasis:entry>4.7</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>13.1</oasis:entry>\n<oasis:entry>12.4</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>10</bold>\n</oasis:entry>\n<oasis:entry>4.0</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>14.5</oasis:entry>\n<oasis:entry>11.1</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>11</bold>\n</oasis:entry>\n<oasis:entry>5.4</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>30.3</oasis:entry>\n<oasis:entry>17.6</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>12</bold>\n</oasis:entry>\n<oasis:entry>14.7</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>74.9</oasis:entry>\n<oasis:entry>72.9</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>13</bold>\n</oasis:entry>\n<oasis:entry>5.9</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>7.0</oasis:entry>\n<oasis:entry>13.7</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>14</bold>\n</oasis:entry>\n<oasis:entry>5.4</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>12.0</oasis:entry>\n<oasis:entry>14.8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>auranofin</oasis:entry>\n<oasis:entry>2.5</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>3.4</oasis:entry>\n<oasis:entry>2.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>cisplatin</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>29.2</oasis:entry>\n<oasis:entry>15</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 2. IC<sub>50</sub> values (\u03bcM) of compounds on different cell lines.\n\n| compd | NIH-3T3 | PC-12 | A-549 | Hep-G2 |\n|-------|---------|-------|-------|--------|\n| 4     | 0.2     | 2.1   | 12.6  | 7.8    |\n| 5     | 0.8     | 2.4   | 95.1  | >100   |\n| 6     | 2.0     | 1.0   | 15.0  | 20.0   |\n| 7     | 13.7    |       | 21.0  | 70.7   |\n| 9     | 4.7     |       | 13.1  | 12.4   |\n| 10    | 4.0     |       | 14.5  | 11.1   |\n| 11    | 5.4     |       | 30.3  | 17.6   |\n| 12    | 14.7    |       | 74.9  | 72.9   |\n| 13    | 5.9     |       | 7.0   | 13.7   |\n| 14    | 5.4     |       | 12.0  | 14.8   |\n| auranofin | 2.5 |       | 3.4   | 2.0    |\n| cisplatin |       |       | 29.2  | 15     |", "data": [[{"meta": {"name": "4", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50", "value": "0.2", "unit": "\u03bcM", "condition": "NIH-3T3"}, {"property name": "IC50", "value": "2.1", "unit": "\u03bcM", "condition": "PC-12"}, {"property name": "IC50", "value": "12.6", "unit": "\u03bcM", "condition": "A-549"}, {"property name": "IC50", "value": "7.8", "unit": "\u03bcM", "condition": "Hep-G2"}]}, {"meta": {"name": "5", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50", "value": "0.8", "unit": "\u03bcM", "condition": "NIH-3T3"}, {"property name": "IC50", "value": "2.4", "unit": "\u03bcM", "condition": "PC-12"}, {"property name": "IC50", "value": "95.1", "unit": "\u03bcM", "condition": "A-549"}, {"property name": "IC50", "value": ">100", "unit": "\u03bcM", "condition": "Hep-G2"}]}, {"meta": {"name": "auranofin", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50", "value": "2.5", "unit": "\u03bcM", "condition": "NIH-3T3"}, {"property name": "IC50", "value": "3.4", "unit": "\u03bcM", "condition": "A-549"}, {"property name": "IC50", "value": "2.0", "unit": "\u03bcM", "condition": "Hep-G2"}]}, {"meta": {"name": "cisplatin", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC50", "value": "29.2", "unit": "\u03bcM", "condition": "A-549"}, {"property name": "IC50", "value": "15", "unit": "\u03bcM", "condition": "Hep-G2"}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 2. IC<sub>50</sub> values (\u03bcM) of compounds on different cell lines.\n\n| compd | NIH-3T3 | PC-12 | A-549 | Hep-G2 |\n|-------|---------|-------|-------|--------|\n| 4     | 0.2     | 2.1   | 12.6  | 7.8    |\n| 5     | 0.8     | 2.4   | 95.1  | >100   |\n| 6     | 2.0     | 1.0   | 15.0  | 20.0   |\n| 7     | 13.7    |       | 21.0  | 70.7   |\n| 9     | 4.7     |       | 13.1  | 12.4   |\n| 10    | 4.0     |       | 14.5  | 11.1   |\n| 11    | 5.4     |       | 30.3  | 17.6   |\n| 12    | 14.7    |       | 74.9  | 72.9   |\n| 13    | 5.9     |       | 7.0   | 13.7   |\n| 14    | 5.4     |       | 12.0  | 14.8   |\n| auranofin | 2.5 |       | 3.4   | 2.0    |\n| cisplatin |       |       | 29.2  | 15     |\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"4\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"0.2\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"NIH-3T3\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"2.1\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"PC-12\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"12.6\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"A-549\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"7.8\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"Hep-G2\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"5\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"0.8\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"NIH-3T3\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"2.4\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"PC-12\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"95.1\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"A-549\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \">100\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"Hep-G2\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"auranofin\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"2.5\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"NIH-3T3\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"3.4\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"A-549\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"2.0\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"Hep-G2\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"cisplatin\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"29.2\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"A-549\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"15\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"Hep-G2\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 59, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<title>DMEM Additives\nand the Cell Numbers Per Well Used for the Experiments</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"3\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">cell line</oasis:entry>\n<oasis:entry align=\"center\">DMEM additive</oasis:entry>\n<oasis:entry align=\"center\">cell number\nper well</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>A-549</oasis:entry>\n<oasis:entry>10% FCS (fetal calf serum)</oasis:entry>\n<oasis:entry>8000</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>NIH-3T3</oasis:entry>\n<oasis:entry>10% FCS</oasis:entry>\n<oasis:entry>6000</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>PC-12</oasis:entry>\n<oasis:entry>10% HOS, 5% NCS (newborn calf serum), 1%\nsodiumpyruvate, 1% <sc>l</sc>-glutamine</oasis:entry>\n<oasis:entry>10000</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>HEP-G2</oasis:entry>\n<oasis:entry>10% FCS</oasis:entry>\n<oasis:entry>10000</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 3. DMEM Additives and the Cell Numbers Per Well Used for the Experiments\n\n| cell line | DMEM additive                                                                                   | cell number per well |\n|-----------|-------------------------------------------------------------------------------------------------|-----------------------|\n| A-549     | 10% FCS (fetal calf serum)                                                                      | 8000                  |\n| NIH-3T3   | 10% FCS                                                                                         | 6000                  |\n| PC-12     | 10% HOS, 5% NCS (newborn calf serum), 1% sodiumpyruvate, 1% l-glutamine                           | 10000                 |\n| HEP-G2    | 10% FCS                                                                                         | 10000                 |", "data": [[{"meta": {"name": "A-549", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "DMEM additive", "value": "10% FCS (fetal calf serum)", "unit": "", "condition": ""}, {"property name": "cell number per well", "value": "8000", "unit": "", "condition": ""}]}, {"meta": {"name": "NIH-3T3", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "DMEM additive", "value": "10% FCS", "unit": "", "condition": ""}, {"property name": "cell number per well", "value": "6000", "unit": "", "condition": ""}]}, {"meta": {"name": "PC-12", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "DMEM additive", "value": "10% HOS, 5% NCS (newborn calf serum), 1% sodiumpyruvate, 1% l-glutamine", "unit": "", "condition": ""}, {"property name": "cell number per well", "value": "10000", "unit": "", "condition": ""}]}, {"meta": {"name": "HEP-G2", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "DMEM additive", "value": "10% FCS", "unit": "", "condition": ""}, {"property name": "cell number per well", "value": "10000", "unit": "", "condition": ""}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 3. DMEM Additives and the Cell Numbers Per Well Used for the Experiments\n\n| cell line | DMEM additive                                                                                   | cell number per well |\n|-----------|-------------------------------------------------------------------------------------------------|-----------------------|\n| A-549     | 10% FCS (fetal calf serum)                                                                      | 8000                  |\n| NIH-3T3   | 10% FCS                                                                                         | 6000                  |\n| PC-12     | 10% HOS, 5% NCS (newborn calf serum), 1% sodiumpyruvate, 1% l-glutamine                           | 10000                 |\n| HEP-G2    | 10% FCS                                                                                         | 10000                 |\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"A-549\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"DMEM additive\",\n                \"value\": \"10% FCS (fetal calf serum)\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"cell number per well\",\n                \"value\": \"8000\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"NIH-3T3\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"DMEM additive\",\n                \"value\": \"10% FCS\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"cell number per well\",\n                \"value\": \"6000\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"PC-12\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"DMEM additive\",\n                \"value\": \"10% HOS, 5% NCS (newborn calf serum), 1% sodiumpyruvate, 1% l-glutamine\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"cell number per well\",\n                \"value\": \"10000\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"HEP-G2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"DMEM additive\",\n                \"value\": \"10% FCS\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"cell number per well\",\n                \"value\": \"10000\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 6, "type": "figure", "classification": null, "content": "<fig fig-type=\"chart\" id=\"cht1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Ferrocene-Based Phosphines\nUsed</title>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0002.tif\"></graphic>\n</fig>", "clean_text": " 1  Ferrocene-Based Phosphines Used   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 8, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Synthesis of the Ferrocenyl Amide-Phosphine Ligands<xref rid=\"sch1-fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0008.tif\"></graphic>\n<p>\n<fn id=\"sch1-fn1\">\n<label>a</label>\n<p>Legend: (i) NH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>PPh<sub>2</sub>, (ii) NH\u00ad(CH<sub>2</sub>CH<sub>2</sub>PPh<sub>2</sub>)<sub>2</sub>.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 1  Synthesis of the Ferrocenyl Amide-Phosphine Ligands      a Legend: (i) NH2CH2CH2PPh2, (ii) NH(CH2CH2PPh2)2.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 10, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Synthesis of Metal\nComplexes with the Ligand PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc<xref rid=\"sch2-fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0009.tif\"></graphic>\n<p>\n<fn id=\"sch2-fn1\">\n<label>a</label>\n<p>Legend: (i) [AuCl\u00ad(tht)]; (ii) <sup>1</sup>/<sub>2</sub> Ag\u00ad(OTf); (iii) [Ag\u00ad(OTf)\u00ad(PPh<sub>3</sub>)].</p>\n</fn>\n</p>\n</fig>", "clean_text": " 2  Synthesis of Metal Complexes with the Ligand PPh2CH2CH2NHCOFc      a Legend: (i) [AuCl(tht)]; (ii) 1/2 Ag(OTf); (iii) [Ag(OTf)(PPh3)].   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 14, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<title>Synthesis of Thiolate Gold Complexes with\nthe Ligand PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHCOFc<xref rid=\"sch3-fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr9\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0010.tif\"></graphic>\n<p>\n<fn id=\"sch3-fn1\">\n<label>a</label>\n<p>Legend: (i) 2-mercaptonicotinic\nacid + K<sub>2</sub>CO<sub>3</sub>; (ii) 2-thiocytosine + K<sub>2</sub>CO<sub>3</sub>; (iii) 2-thiouracil + K<sub>2</sub>CO<sub>3</sub>;\n(iv) 2-mercaptopurine + K<sub>2</sub>CO<sub>3</sub>.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 3  Synthesis of Thiolate Gold Complexes with the Ligand PPh2CH2CH2NHCOFc      a Legend: (i) 2-mercaptonicotinic acid + K2CO3; (ii) 2-thiocytosine + K2CO3; (iii) 2-thiouracil + K2CO3; (iv) 2-mercaptopurine + K2CO3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 17, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<title>Synthesis of Gold\nComplexes with the Ligand (PPh<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>NCOFc<xref rid=\"sch4-fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr10\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0011.tif\"></graphic>\n<p>\n<fn id=\"sch4-fn1\">\n<label>a</label>\n<p>Legend: (i) 2 [AuCl\u00ad(tht)]; (ii)\n2-thiocytosine + K<sub>2</sub>CO<sub>3</sub>; (iii) 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-<sc>d</sc>-glucopyranosato + K<sub>2</sub>CO<sub>3</sub>.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 4  Synthesis of Gold Complexes with the Ligand (PPh2CH2CH2)2NCOFc      a Legend: (i) 2 [AuCl(tht)]; (ii) 2-thiocytosine + K2CO3; (iii) 2,3,4,6-tetra-6-acetyl-1-thiol-\u03b2-d-glucopyranosato + K2CO3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 20, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Molecular structure for\ncompound <bold>8</bold> with 50% probability ellipsoids. Hydrogen\natoms are omitted for clarity. Selected bond lengths (\u00c5) and\nangles (deg): Au(1)\u2013P(1) = 2.233(2), Au(1)\u2013Cl(1) = 2.294(2),\nAu(2)\u2013P(2) = 2.228(2), Au(2)\u2013Cl(2) = 2.292(2); P(1)\u2013Au(1)\u2013Cl(1)\n= 174.35(9), P(2)\u2013Au(2)\u2013Cl(2) = 173.17(9).</p>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0003.tif\"></graphic>\n</fig>", "clean_text": " 1  Molecular structure for compound 8 with 50% probability ellipsoids. Hydrogen atoms are omitted for clarity. Selected bond lengths (\u00c5) and angles (deg): Au(1)-P(1) = 2.233(2), Au(1)-Cl(1) = 2.294(2), Au(2)-P(2) = 2.228(2), Au(2)-Cl(2) = 2.292(2); P(1)-Au(1)-Cl(1) = 174.35(9), P(2)-Au(2)-Cl(2) = 173.17(9).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 22, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Polymer chain of complex <bold>8</bold> though intermolecular aurophilic interactions. Selected\nbond lengths (\u00c5) and angles (deg): Au(1)\u2013Au(2) = 3.2816(5);\nP(1)\u2013Au(1)\u2013Au(2) = 110.76(6), P(2)\u2013Au(2)\u2013Au(1)\n= 91.64(6).</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0004.tif\"></graphic>\n</fig>", "clean_text": " 2  Polymer chain of complex 8 though intermolecular aurophilic interactions. Selected bond lengths (\u00c5) and angles (deg): Au(1)-Au(2) = 3.2816(5); P(1)-Au(1)-Au(2) = 110.76(6), P(2)-Au(2)-Au(1) = 91.64(6).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Thiolate gold complexes prepared from <bold>L3</bold> and dppf.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0005.tif\"></graphic>\n</fig>", "clean_text": " 3  Thiolate gold complexes prepared from L3 and dppf.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Molecular structure of complex <bold>13</bold> with atom-labeling scheme. Hydrogen atoms have been omitted. Radii\nare arbritrary. Selected bond lengths (\u00c5) and angles (deg): Au(1)\u2013P(1)\n= 2.280(4), Au(1)\u2013S(1) = 2.319(5), Au(2)\u2013P(2)#1 = 2.266(4),\nAu(2)\u2013S(2) = 2.301(4); P(2)#1\u2013Au(2)\u2013S(2) = 177.44(16),\nP(2)#1\u2013Au(2)\u2013Au(1) = 104.31(8). Symmetry transformation:\n(#1) \u2212<italic toggle=\"yes\">x</italic> + <sup>1</sup>/<sub>2</sub>, \u2212<italic toggle=\"yes\">y</italic> + 2, <italic toggle=\"yes\">z</italic> + <sup>1</sup>/<sub>2</sub>.</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0006.tif\"></graphic>\n</fig>", "clean_text": " 4  Molecular structure of complex 13 with atom-labeling scheme. Hydrogen atoms have been omitted. Radii are arbritrary. Selected bond lengths (\u00c5) and angles (deg): Au(1)-P(1) = 2.280(4), Au(1)-S(1) = 2.319(5), Au(2)-P(2)#1 = 2.266(4), Au(2)-S(2) = 2.301(4); P(2)#1-Au(2)-S(2) = 177.44(16), P(2)#1-Au(2)-Au(1) = 104.31(8). Symmetry transformation: (#1) -x + 1/2, -y + 2, z + 1/2.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 28, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Formation\nof a polymer chain through aurophilic interactions. Selected bond\nlengths (\u00c5) and angles (deg): Au(1)\u2013Au(2) = 3.010(3);\nP(1)\u2013Au(1)\u2013Au(2) = 97.61(9), S(1)\u2013Au(1)\u2013Au(2)\n= 80.92(10), P(2)#1\u2013Au(2)\u2013Au(1) = 104.31(8), S(2)\u2013Au(2)\u2013Au(1)\n= 75.74(9). Symmetry transformation: (#1) \u2212<italic toggle=\"yes\">x</italic> + <sup>1</sup>/<sub>2</sub>, \u2212<italic toggle=\"yes\">y</italic> + 2, <italic toggle=\"yes\">z</italic> + <sup>1</sup>/<sub>2</sub>.</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2013-00633z_0007.tif\"></graphic>\n</fig>", "clean_text": " 5  Formation of a polymer chain through aurophilic interactions. Selected bond lengths (\u00c5) and angles (deg): Au(1)-Au(2) = 3.010(3); P(1)-Au(1)-Au(2) = 97.61(9), S(1)-Au(1)-Au(2) = 80.92(10), P(2)#1-Au(2)-Au(1) = 104.31(8), S(2)-Au(2)-Au(1) = 75.74(9). Symmetry transformation: (#1) -x + 1/2, -y + 2, z + 1/2.   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/om400633z", "title": "\nAntitumoral Gold and Silver Complexes with Ferrocenyl-Amide\nPhosphines\n", "journal": "American Chemical\nSociety", "date": "2013.10", "author_list": ["Goitia\nHelen", "Nieto\nYolanda", "Villacampa\nM. Dolores", "Kasper\nCornelia", "Laguna\nAntonio", "Gimeno\nM. Concepcio\u0301n"]}}